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ABSTRACT 
Background 
Iodine is an essential nutrient for the synthesis of thyroid hormones. Inadequate iodine intake 
is especially critical during pregnancy, lactation and early childhood. Iodine deficiency early 
in life impairs the developing brain. Iodine deficiency is defined as a median urine 
concentration less than 150 µg/ L in pregnant women. Seafood, milk-and dairy products, eggs 
and iodine-containing supplements are dietary iodine sources in Norway. Recently studies 
indicate that iodine status in pregnant women could be suboptimal. 
Aims 
The aims of the study were: [1] to determinate the iodine status of the pregnant women based 
on urinary iodine concentration from a spot urine sample using the World Health 
Organization (WHO). [2] to estimate the iodine intake from selected food groups and iodine-
containing supplements using a food frequency questionnaire (FFQ) to evaluate whether or 
not it is in accordance with the Norwegian recommendation. [3] to assess influence of some 
factors (e.g. weeks of gestation, timing and season of spot urine collection) on the urinary 
iodine concentration (UIC) during pregnancy. 
Methods 
A total of 1036 pregnant women included in the study were recruited within the period 2011 – 
2012 from nine well-baby clinics across the Norwegian Health Regions. A spot urine sample 
(to measure UIC) was collected from 1008 participants at the first meeting in the clinic. UIC 
were determined using inductively couple plasma spectrometry (ICP-MS). A self-
administrative, semi quantitative FFQ (to estimate iodine intake) were filled in at home from 
833 participants. 
Results 
Median UIC was 82 µg/ L and 80% of the urine samples were below 150 µg/ L. Data from 
the FFQ revealed that 30% ate seafood 2 – 3 times per week at dinner, 68% ate milk-and 
dairy products 2 – 3 times per day and 39% ate egg 2 – 3 times per week.  Iodine-containing 
supplements were reported by 14% of the women. The total median iodine intake from foods 
and supplements was 153 µg/ day. Intake of milk-and dairy products and gestational age 
correlated significantly with median UIC. 
Conclusions 
Findings in the present study from median UIC classify the pregnant women as iodine 
deficient. Estimated dietary iodine intake also shows inadequate iodine intake among the 
women. In conclusion, this study shows that the diet of the pregnant women does not secure a 
sufficient iodine intake and one strategy to increase the iodine intake could be to increase the 
seafood intake. 
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1. INTRODUCTION 
 
1.1 Background 
Iodine is an essential trace element for the production of thyroid hormone (TH). Inadequate 
iodine intake is a challenge on a population level in several countries and iodine deficiency 
(ID) is recognized as the most important cause of mental retardation. The severity of the 
damage in the central nervous system is not only related to nutritional deficiency of iodine, 
but also with the stage of development during which it occurs. The intake of iodine should be 
sufficient to meet the nutritional needs and an adequate supply of iodine is especially 
important in pregnancy and lactation and during the early childhood. In some countries like 
Norway, national representative survey data on iodine intake and iodine status, especially 
during pregnancy are limited (Li and Eastman 2012). 
The iodine intake of a population is often assessed by determination of iodine concentration in 
a casual sample of urine and it is classified as adequate with median values above 150 µg/ L 
given by the World Health Organization (WHO) for pregnant women. 
The main source of iodine in humans is the food. In Norway, seafood, milk-and dairy 
products and eggs have the highest iodine content. Other food groups such as meat and meat 
products, bread and cereals, fruits and vegetables have low levels of iodine. Iodized salt is the 
most important source of iodine worldwide. Although iodized salt is available in Norway, the 
level of iodization is very low. Supplement could also be an important source of iodine.  
Several surveys in previously iodine-sufficient countries such as Australia, UK, USA, New 
Zealand, Switzerland, Ireland, France, Spain, Hong Kong and Belgium (Zimmermann 2011, 
Li and Eastman 2012) have shown that mild-to-moderate ID has re-emerged in vulnerable 
groups such as pregnant women (Stagnaro-Green and Pearce 2013, WHOa 2014).  
A recently performed study in Norway “The Fjell Study” including 64 pregnant women found 
that the median urinary iodine concentration (MUIC) was 127 µg/ L (Seldal 2012).  Results 
from 119 pregnant women in the Norwegian Mother and Child Cohort study (MoBa) found a 
MUIC of 69 µg/ L (Brantsæter, Abel et al. 2013). Both studies indicate that iodine status of 
pregnant women in Norway could be suboptimal (Brantsæter, Abel et al. 2013) regardless of 
the population size. Moreover, MoBa study showed by using a frequency food questionnaire 
(FFQ) that 54.3% of pregnant women had an insufficient iodine intake (Brantsæter, Abel et 
al. 2013).  
Based on findings in those two Norwegian studies; the present thesis will evaluate the iodine 
status of 1036 pregnant women who were recruited to the “Little in Norway” study by 
measuring MUIC and by estimation of dietary iodine intake.  
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1.2 Global iodine nutrition 
Although ID is often considered to be a primarily challenge of developing countries, 
industrialized countries are not immune (Zimmermann 2010, Li and Eastman 2012, Bath, 
Steer et al. 2013, Stagnaro-Green and Pearce 2013). Among the WHO Regions, Europe has 
the highest prevalence of ID with a 44 % of the population remaining mildly iodine deficient 
(Andersson, Karumbunathan et al. 2012, Ristic-Medic, Novakovic et al. 2013). 
Iodine Global Network (IGN) estimates that nearly 29.8 % (241 million) of the world’s 
population continue to have insufficient iodine intake and the situation is still affecting 30 
countries (Andersson, Karumbunathan et al. 2012, Pearce, Andersson et al. 2013, IGN 2014), 
distributed as moderately deficient (9 countries), mildly deficient (21 countries) and 
fortunately none are currently severe iodine deficient (Fig. 1).  
Further, it is critical that there are insufficient data from nearly all countries to estimate the 
prevalence of ID in pregnant women (Zimmermann 2010), but just in developing countries, 
there are 38 million newborn babies per year are at risk of ID (Li and Eastman 2012) despite 
ongoing and concerned efforts by WHO, the United Nations (UN) and IGN (Stagnaro-Green 
and Pearce 2013) to avoid that it may become a public health problem (Brantsæter, Abel et al. 
2013) with a national and international interest. 
 
Figure 1. National iodine status
ii
 elaborated by (Pearce, Andersson et al. 2013) 
 
 
  
                                                          
ii Figure based on median urinary iodine concentrations in school-age children 
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1.3 Biological function of iodine 
Iodine (atomic symbol I) is an essential component of thyroid hormones (THs). In humans, 
iodine is present in the thyroid gland which is responsible for its synthesis, storage and 
secretion in the body (Zimmermann, Jooste et al. 2008, Erdman, MacDonald et al. 2012, Bath 
and Rayman 2013). 
The tyrosine-based hormones are T4 (Thyroxine) and T3 (Triiodothyronine) (Fig. 2). It is 
believed that both T4 and T3 are active hormones, having the last one, the highest biological 
activity in the body (Mari Nes 2006). 
 
Figure 2. Thyroid hormones 
 
THs are needed for adequate growth and development of tissues and metabolism of the body 
and for adequate neuronal migration and myelination of the fetal and neonatal brain 
(Zimmermann 2012). This maintains the body temperature, increase the absorption of glucose 
in the intestine and break down fat and glycogen. It must be mentioned that the regulation 
mechanism during pregnancy is not completely understood (Zimmermann 2009), however the 
hormones are  necessary to development of hearing and vision and maturation of most organs 
like brain, muscle, hearth, pituitary, reproductive system and bones (IOM 2001 ). 
1.4 Iodine metabolism during pregnancy 
Normally, the body of a healthy adult contains up to 15 – 20 mg of iodine. The ingested 
inorganic iodine and iodate (extensively used in salt iodization) are nearly completely 
absorbed from the gastrointestinal tract (Zimmermann 2010, Erdman, MacDonald et al. 2012, 
Li and Eastman 2012) (Fig. 3). It has been estimated that more than 90% of ingested iodine is 
ultimately excreted in the urine, being the kidney the main route of excretion; about 20% are 
excreted in the feces, 5% appear in the sweat, saliva and the bile. Lactating women excretes 
10 – 15% of the daily iodine intake into breast milk (SCF 2002, IOM 2001 ). 
Hormonal and metabolic changes during normal pregnancy occur due to the hormone 
requirements and bioavailability of iodine (Glinoer 1997, Glinoer and Delange 2000) (Fig. 4). 
In pregnancy, iodine intake should be increased ≥ 50% (Zimmermann 2012) due to the: 
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Increased production of TH, elevate renal clearance of iodine and transfer of maternal iodine 
and TH to the fetus. 
 
Figure 3. Thyroid hormone synthesis (thyroMend 2013) 
[1] Increased production of thyroid hormone: During the first half of pregnancy, elevated 
levels of THs are needed to control maternal euthyroidism
iii
 (Trumpff, De Schepper et al. 
2013). At the beginning of the second trimester TH concentrations are 30 – 100% higher than 
before conception (Fantz, Dagogo-Jack et al. 1999).  
[2] Elevate renal clearance of iodine: During normal pregnancy, higher iodine losses occurs 
due to the increase in renal iodine clearance (RIC) due to abundance of oestrogen (Eltom, 
Eltom et al. 2000) and the increase of glomerular filtration rate (GFR) (Trumpff, De Schepper 
et al. 2013). GFR begins to rise during pregnancy, becoming a mandatory renal iodine 
“leakage” (Glinoer 1997)highlighting conferred). 
Later, during the second half of pregnancy, an iodine loss takes place from the passage of a 
part of the available iodine from the mother to the fetus, which starts to produce TH in order 
to keep a normal fetal brain development. Therefore, when iodine needs exist during the first 
half of gestation, it tends to become more severe in the second half of gestation (Glinoer 
1997). 
[3] Transfer of maternal iodine and thyroid hormone to the fetus: Thyroid development 
of the fetus starts at 10 – 12 weeks of gestation and from the 18 – 20th weeks T4 is secreted by 
                                                          
iii
 The state of having normal thyroid function. 
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the fetal thyroid gland. Iodine is transferred through the placenta from the mother to the fetal 
thyroid gland and the fetus starts to produce its own TH (Trumpff, De Schepper et al. 2013) 
 
Figure 4. Iodine metabolism in pregnancy elaborated by(Glinoer and Delange 2000) 
 
1.5 Health consequences of deficiency and excess of iodine 
1.5.1 Iodine deficiency disorders (IDD) 
ID leads to severe clinical effects on the development and growth of animal and humans 
(Zimmermann 2010, Andersson, Karumbunathan et al. 2012, Erdman, MacDonald et al. 2012, 
Zimmermann 2012). These clinical effects are considered as iodine deficiency disorders 
(IDD) (Hetzel 1983, WHOa 2014) due to the inadequate TH production. The main impact of 
ID is on pregnancy, lactating women and during the first two years of life (Andersson, de 
Benoist et al. 2007). 
ID cause mental impairment, motor and physical deficits in utero and childhood (Pardede, 
Hardjowasito et al. 1998, Bhutto, Hurrell et al. 2012, Bath, Steer et al. 2013, Hynes, Otahal et 
al. 2013). Conversely, early and adequate iodine in the mother improve head growth, reduce 
the prevalence of microcephaly (Cao, Jiang et al. 1994), increase birthweight, weight-for-age 
(WFA), mid-upper-arm circumference (MUAC) (Chaouki and Benmiloud 1994, Mason, 
Deitchler et al. 2002) and may reduce the infant mortality rate (IMR) by ≥ 50% (Cobra, 
Rusmil et al. 1997) in the infant. Moreover, two controlled trials in school age children (SAC) 
affirm that iodine repletion contribute to a positive cognitive function and information 
processing, fine motor skills and improve visual problem in mild and moderately iodine 
deficient children (Zimmermann, Connolly et al. 2006, Gordon, Rose et al. 2009). However, 
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the cognitive deficit may not be associated only with infant and children whose mother was 
iodine deficient because in children without IDD but residing in areas of ID, a neuro - 
psychomotor retardation occur (Boyages, Collins et al. 1989, Azizi, Kalani et al. 1995). 
The effects of ID become more evident during pregnancy (Trumpff, De Schepper et al. 2013) 
with increased incidence of intrauterine fetal death, infant mortality, preterm delivery, 
frequency of caesarian section and congenital abnormalities like cretinism which is 
considered as extreme expression of the abnormalities (Delange, de Benoist et al. 2001, 
UNICEFc 2008). Severe ID and hypothyroidism during pregnancy leads to impaired 
neurological development in the children (Li and Eastman 2012). 
Adequate iodine intake is important during pregnancy, but there is no evidence about whether 
the mother or the child who has the most damage in mild ID (Laurberg, Andersen et al. 2007). 
Therefore, an iodine supplementation before, and during pregnancy is recommended on both 
mother and fetus.   
IDD is the most common cause of goiter in all ages (IGN/UNICEF/WHO 2007). (Glinoer, 
Lemone et al. 1992, Rotondi, Amato et al. 2000)and(Knudsen, Bulow et al. 2002)referred to 
by(Braverman and Cooper 2012)suggest that: “goiters formed during pregnancy may only 
partially regress after parturition”.   
1.5.2 Iodine excess 
It has been reported that ten countries had national MUIC in SAC > 300 μg/ L in 2011 
(Andersson, Karumbunathan et al. 2012, Pearce, Andersson et al. 2013). The reported ten 
countries were classified as excessive according to the WHO.  In pregnant women, a MUIC 
between 250 and 499 μg/ L is considered more than adequate, whereas a MUIC ≥ 500 µg / L 
is considered excessive (IGN/UNICEF/WHO 2007). Few studies have associated excessive 
iodine intake with adverse effects in pregnant women (Sang, Wei et al. 2012). However, it is 
undeniable that either excessive or deficient, iodine intake can cause alterations in thyroid 
function (Pearce, Andersson et al. 2013). 
It has been reported cases of hypothyroidism, hyperthyroidism, thyroiditis, Grave`s disease 
(Laurberg., Andersen. et al. 2007, Erdman, MacDonald et al. 2012, IOM 2001 ) and thyroid 
papillary cancer in some individuals with excess iodine intake (IOM 2001 ). The exact dose/ 
response association between higher iodine intake and  hypothyroidism is unknown at present 
(Laurberg., Andersen. et al. 2007) 
Acute iodine poisoning is associated with burning of the mouth, throat, gastrointestinal 
irritation, abdominal pain, fever, nausea, vomiting, diarrhea, weak pulse, cardiovascular 
symptoms, cyanosis and even coma (Erdman, MacDonald et al. 2012, IOM 2001 ). 
1.6 Assessment of iodine status 
Several methods to assess iodine status depend of their performance, available resources, the 
age or life stage of the subjects, dietary partners, the iodine status of the study group and the 
study objectives to be used (Ristic-Medic, Piskackova et al. 2009). In some studied groups, 
urinary iodine (UI), newborn thyroid-stimulating hormone (TSH) and blood concentrations of 
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thyroglobulin (Tg), T4 and T3, are useful biomarkers of iodine status indicating the recent 
iodine intake in days (UI), weeks to months (Tg), months to years ( changes in the goiter rate 
reflecting long term iodine nutrition) (Zimmermann 2008, Erdman, MacDonald et al. 2012).  
Elevated TSH levels have been used to assess the severity of ID in neonates (Trumpff, De 
Schepper et al. 2013). Iodine levels are lower in neonates than in adults, but has higher rates 
of iodine turnover therefore a TSH stimulation is increased when the iodine supply is low 
(Erdman, MacDonald et al. 2012).  
Serum Tg is a hopeful biomarker for monitoring thyroid function and abnormalities in 
populations studies which seems to correlate with UIC (Hambidge 2003, Ristic-Medic, 
Piskackova et al. 2009). However, a high serum concentration of Tg is not a specific sign of 
ID (Laurberg, Andersen et al. 2007, Ristic-Medic, Piskackova et al. 2009).  
TH concentrations are generally less sensitive indicators of iodine status (Erdman, 
MacDonald et al. 2012), unless iodine deficiency is severe (Zimmermann 2010).  A moderate 
fall in the concentration of serum free T4 during pregnancy is insufficiently sensitive to be 
used as indicator of maternal ID (Laurberg, Andersen et al. 2007). 
Size of thyroid gland increases during ID (including during pregnancy) (IOM 2001 ).Thyroid 
size is recommended by WHO/UNICEF/IGN and classified goiter by palpation: grade 0 (no 
goiter), grade I (a goiter palpable but not visible when the neck is in normal position) and 
grade II (visible goiter). However when the thyroid is small, a ultrasounds is indicated 
(Delange, de Benoist et al. 2001).  
1.6.1 Urinary iodine (UI) 
Considering that > 90% of dietary iodine eventually appears in the urine (Travers, Guttikonda 
et al. 2006, Erdman, MacDonald et al. 2012, Li and Eastman 2012, Zimmermann 2012), the 
UI is widely use as biochemical marker of iodine status in the absence of other more – stable 
practical biomarker and because it reflects a recent dietary iodine intake (a few days) 
(Hambidge 2003, Ristic-Medic, Piskackova et al. 2009). The WHO recommendations for 
using the MUIC from spot – urine samples are established as cut offs to indicate iodine 
sufficiency in populations and are shown in Table 1. 
UI can be expressed as a concentration (µg/ L) or as a 24-hour excretion (µg/ day), in 
relationship to creatinine excretion (µg iodine/ g creatinine) (Busnardo, Nacamulli et al. 2006, 
Konig, Andersson et al. 2011).  A 24- hour collections of urine is also used, however the 
collection of urine is more inconvenient for the subjects, by using a larger sample of spot 
urines, the  variation in hydration among the individuals and day to day variation in the iodine 
intake generally even out, so that the MUIC is suitable marker of iodine intake (Zimmermann 
and Andersson 2012). To determinate reliability of surveys with a certain number of urine 
samples 100 – 500 spot urine samples are required (Hurrell 1997). 
It has been reported that a single spot UIC is not suitable indicator for individual assessment 
(Konig, Andersson et al. 2011) due to the values are not normally distributed and only the 
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median, in µg / L can be used to classify iodine intake of the entire group (Laurberg., 
Andersen. et al. 2007).  
 
1.7 Assessment of food intake 
The iodine status refers to the median casual UIC as a reflection of iodine intake (van den 
Briel, West et al. 2001, Wong, Sullivan et al. 2011); therefore, another method to assess 
iodine is to calculate the iodine intake direct from the diet. 
In epidemiological studies, self-report methods may give information about diet and other 
factors related to live style and health without being invasive; therefore the questions asked 
should be easy to administer and less time-consuming, but still give useful information (NOO 
2011). 
The choice of a dietary method depends on many factors as the purpose of the study, the 
number of subjects to be surveyed, the food and nutrient of interest, short or long term intake, 
dietary habits and nutrient intakes with respect to the dietary recommendations, characteristics 
of the population and the resources (Seldal 2012). A FFQ meets these demands (Rasmussen, 
Ovesen et al. 2001) and can be used to classify low and high iodine intake groups 
(Brantsaeter, Haugen et al. 2008). In order to assess the dietary intake of iodine in a 
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population and in sub groups of the population, accurate data are needed regarding the iodine 
content of the different food groups, as well as food consumption data (personal 
communication Lisbeth Dahl).  
A comparison between FFQ and other methods of dietary assessment as food diaries or 24-h 
food intake recalls and weighed food records indicate that a FFQ give more precise 
information of a long-term intake (usually 1 year) (Ortiz-Andrellucchi, Doreste-Alonso et al. 
2009, Seldal 2012).  
A FFQ is a retrospective review of intake frequency (i.e. food consumed per day, per week, or 
per month) useful in epidemiological studies (Ortiz-Andrellucchi, Doreste-Alonso et al. 
2009). FFQs assess the frequency and portion sizes of iodine-containing foods and/or food 
groups consumed and captures iodine-rich sources that are irregularly consumed and accounts 
due to the day-to-day variation of the major dietary patterns (Zimmermann and Andersson 
2012). Because the aim of the FFQ is the frequency on consumption of food groups rather 
than of specific, for certain nutrients; the level of nutrient intake estimated by FFQ should be 
regarded as approximations (Brantsaeter 2007). 
Short FFQs may be used to measure the relationship between consumption of several specific 
foods or nutrients (Eysteinsdottir, Thorsdottir et al. 2012), while long FFQs pretend to give a 
comprehensive assessment of  the whole diet (Seldal 2012). 
1.8 Dietary sources of iodine 
Iodine is obtained primarily through the diet (Brantsæter, Abel et al. 2013). The main source 
of iodine in the Norwegian diet is milk-and dairy products due to its frequent intake. Higher 
milk/ yogurt intake than 200 – 300 ml/ day (1 – 2 serving) is needed to obtain 150 µg iodine 
daily (Brantsæter, Abel et al. 2013).  
Marine fish and other seafood contribute also with iodine (Bhutto, Hurrell et al. 2012) with a 
range of 5 – 380 μg (NorwegianFoodSafetyAuthority 2014). Lean fish contains twice as much 
iodine, as oily fish, although there are very large variations e.g. cod, haddock and saithe (86 
µg I/ 100 g) have higher levels of iodine in the fillet than typical fatty fish species such as 
farmed salmon, herring, mackerel (40 µg I/ 100 g) (Preedy, Burrow et al. 2009). Marine 
sources contain more iodine than terrestrial vegetables (TheNorwegianDirectorateofHealth 
2011). 
Eggs provides 45 µg I/ 100 g (Dahl, Johansson et al. 2004), dependent on the chicken feed 
(Vanderpump and reply. 2011). According to the new version of Norwegian Food 
Composition Database 2014, raw egg, raw egg whites and raw egg yolk contains 49 µg, 3 µg 
and 120 µg iodine respectively per 100 g.  
Other foodstuffs e.g. meat and meat products, bread and cereals, vegetables, potatoes, fruits 
and berries, and fats and oils contain 2 – 3 µg I/ 100 g providing a limited amount of iodine to 
the total iodine intake (Dahl, Johansson et al. 2004). 
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In Norway, a study showed that multi- or single- vitamin preparations and mineral 
supplements were the most frequently used supplements (Brantsaeter, Haugen et al. 2007). 
Pregnant women should receive once-daily iodine-containing supplement (150 μg) 
(Zimmermann and Delange 2004). One prenatal vitamin should contain between 150 and 200 
μg iodine/ table (Dinc, Cakar et al. 2013) although other interventional studies which include 
supplementation, recommends lower, similar or higher doses (Brucker-Davis, Panaia-Ferrari 
et al. 2013). 
One major dietary source of iodine is iodised table. Actually, 76% of the world is estimated to 
be covered by iodized salt (UNICEFa 2014). In Norway, voluntary iodized salt is not 
extensively used due to the low contribution of iodine from some brands of table salt (5 µg I/g 
Na Cl) compared to other sources of iodine (Opsahl 2002).  In industrialized countries, the 
average amount of reported salt use per capita is 10 g/ day and only 1 g of household salt is 
consume daily. The intake of 3 g table salt /day contributes with 15 µg I if used (Dahl, Opsahl 
et al. 2003). Therefore, the use of iodised salt in the food industry will supplant the deficiency 
of iodine in the most part of the population (Zimmermann 2010, Zimmermann 2011). 
1.9 Dietary recommendations of iodine 
In the Nordic countries, the recommendations of iodine has been set at 150 µg/ day for 
children 10 years and older, 175 µg/ day for pregnant and 200 µg/ day for lactating, according 
to the Nordic Nutrition Recommendations (NNR5 2012) (TheNodicCouncilofMinisters 2013, 
TheNorwegianDirectorateofHealth 2014). The lowest and the maximum intakes per day are 
70 μg and 1 mg iodine, respectively. WHO, the United Fund for Children (UNICEF) and the 
IGN established a recommend intake of 250 µg/ day for pregnant and lactating women.  
The European Food Safety Authority (EFSA) and The Institute of the United States (IOM) 
have established Upper levels (UL) of iodine at 600 μg /d and 1100 μg/d respectively (SCF 
2002, IOM 2001 ). These levels are considered safe for healthy adults including pregnant and 
lactating women according to EFSA (Flynn, Hirvonen et al. 2009). However, although most 
individuals tolerate high dietary intakes remarkably well (Pearce, Andersson et al. 2013) and 
no altered susceptibility has been noted, a higher daily intake of 500 µg during pregnancy is 
excessive (Andersson, de Benoist et al. 2007). 
 
 
 
 
 
 
 
 
  
Table 2. Recommended iodine intake (µg per day)† 
Age or Population Group 
 
Recommended Iodine Intake  
(μg per day) 
1 – 2 y 70 
3 – 5 y 90 
6 – 9 y 120 
10 – >75 y 150 
Pregnant  175 
Lactating 200 
†
Modified from the table of Norwegian nutrient recommendations 2014 
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1.10 Aims of the study 
The overall aim of the present thesis is to assess the iodine status of pregnant women which 
participated in the “Little in Norway” (Liten i Norge-LiN) study. 
The specific objectives of the thesis were:  
[1] To determinate the iodine status of the pregnant women based on urinary iodine 
concentration (UIC) from a spot urine sample using the epidemiological criteria from World 
Health Organization (WHO). 
[2] To estimate the iodine intake from selected food groups and iodine-containing 
supplements using a food frequency questionnaire (FFQ) to evaluate whether or not it is in 
accordance with the Norwegian recommendation. 
 [3] To assess influence of some factors (e.g. weeks of gestation, timing and season of spot 
urine collection) on the urinary iodine concentration during pregnancy. 
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2. MATERIALS AND METHODS 
This thesis is part of LiN study, which is a population prospective cohort study aiming at 
generating new knowledge about infant and early childhood mental health and development 
from pregnancy to age 18 months.   
LiN project is a collaboration between the National Network for Infant Mental Health in 
Norway, at the Regional Center for Child and Adolescent Mental Health East and South. 
National Institute of Nutrition and Seafood Research (NIFES) is responsible for the 
nutritional part of the project. The Regional Committees for Medical Research Ethics has 
approved the study. LiN is not registered in clinical trials because this study qualifies as non-
interventional. 
2.1 Participants and recruitment 
The participants were pregnant women recruited between September 2011 and mid-October 
2012 from nine well-baby clinics across the Norwegian Health Regions. The data collection 
consisted of five phases namely: t1 (enrolment, week 8 - 34), t2 (week 20 - 25), t3 (week 26 - 
31), t4 (week 32 – 34) and t5 (week 36) and time of birth. The phases were based on the time 
of the gestational age the mother at the moment of enrolment. Data collection up to age 18 
months ended in November 2014. 
At the first meeting in the clinic, the mothers filled in several questionnaire (i.e. 
sociodemographic questionnaires) (t1) and were asked to provide a urine sample (t1 and t3). 
The FFQ was within one week send to the mothers by e-mail and filled in at home (t1-t5). 
Figure 5 shows an overview of the data collection at inclusion (different “t”) and during 
pregnancy. In the present master thesis, results from t1 are presented. 
The questionnaires were answered electronically using a program called “Confirmit”. The 
answers were transferred and recorded directly in an SPSS file. The FFQ and 
sociodemographic's file contained a raw data and therefore data clean and data conversion 
efforts were needed. The files were merged into a single file after that.  
2.2 Determination of iodine in the diet 
2.2.1 Data collection 
Iodine in the diet was assessed using a part of a self – administrate, semi quantitative FFQ for 
dietary intake (t1 and t4) as well as a very short FFQ (3 questions only) with focus only in oily 
- lean fish consumption during dinner and the use of supplements (t2,t3 and t5). The FFQ was 
in Norwegian and based on the validated seafood FFQ (Dahl, Maeland et al. 2011) and the 
seafood index (Markhus, Graff et al. 2013).  
All questions from FFQ have variable names starting with “Sjo” and it's followed by the letter 
“T” and a number which stands for the data collection phase. Then the number corresponding 
to each question in the questionnaire comes e.g. “SjoT4_1”. Some questions have sub-
questions and come with the corresponding number, e.g. “SjoT4_1_1” (see Appendix). The 
variable name from sociodemographic questionnaire is according to the question. This system 
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allows that each question has a variable and the data of multiple phases are recorded in the 
same file.  
 
Figure 5. Flow chart describing Little in Norway study 
 
2.2.2. Frequency food questionnaire: Seafood 
The FFQ asked for dietary habits of the seafood consumption for the last three months. For 
the purposes of this thesis, there were considered only those questions related to seafood 
consumption of seafood as dinner, spread salads or as snack meal divided in main and item 
questions, and the use of supplements containing iodine. It was also possible to register other 
seafood species and supplement brands not given in the questionnaire (“other seafood” and 
“other supplements”). 
Frequency of consumption of seafood was recorded in six options: “never”, “less than once 
per month”, “one to three times per month”, “one time per week”, “two to three times per 
week”, “four times or more per week” in the main question for dinner and “never”, “rarely”, 
“one to three times per month”, “one to two times per week”, “three to five times per week”, 
”more than five times per week” in the main question for spread. 
Frequency intake of seafood as dinner and spread in the item questions was also recorded in 
five options: “never”, “less than once per month”, “one to three times per month”, “one to two 
times per week”, “three or more per week”. 
The portions size was recorded in five options: “half a portion or les”, “one portion”, “one a 
half portion”, “two portions”, and "three portions” iv 
 
  
                                                          
iv
 1 portion = 150 g 
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Seafood categories 
Seafood was grouped into six categories: “oily fish”, “lean fish”, “freshwater fish”, 
“shellfish”, “sushi” and “processed fish”. It must be emphasized that to elaborate the 
categories it was considered the definitions of the Norwegian Scientific Committee for Food 
Safety 2007 (VKM), this mean; oily and lean fish (including half oily fish) if a fish contains > 
5 g fat/100 g and < 5 g fat/100 g respectively; processed fish which does not include spread 
and typically consist of 40 – 60% oily fish filled. Within the category "freshwater fish", perch/ 
pike and char/powan were nominated in two different items. The first and the second item 
include lean fish and oily fish respectively. The reason why these fish were not re grouped 
within their respective categories was because it would not have been able to identify the 
frequency of consumption individually. However, these were re-grouped to make a 
calculation of the contribution of each seafood category. 
2.2.3. Frequency food questionnaire: Milk-and dairy products 
Milk and dairy products (milk, yogurts, and cheese) were reported as follows: “yes” (the 
person consumes) or “not”. If the mother indicates “yes”, the next option was to indicate the 
daily frequency of consumption as: “one time per day”, “two to three times per day”, “four to 
five times per day”, “seven to nine times per day” and “ten or more times per day”. 
Consumption of different products fortified with vitamin D was not considered in this thesis. 
2.2.4. Frequency food questionnaire: Eggs 
Weekly consumption of eggs as fried, boiled, scrambled eggs and omelet was recorded as: 
“less than one egg per week”, “one egg per week”, “two to three eggs per week”, “four to five 
eggs per week”, “six to seven eggs per week” and “eight or more eggs per week”. 
2.2.5. Frequency food questionnaire: Multivitamin and mineral supplements 
The use of multivitamin and mineral supplements was entered as: “never use”, “one to three 
times per month”, “one to three times per week”, “four to six times per week” and “daily”. 
2.2.6. The seafood index 
Recently in Norway, it was established and validated a seafood index from seafood FFQ to 
capture seafood consumption in pregnant women and since seafood is a good source of 
iodine, the present study used the seafood index to assess iodine intake. 
[1] For estimation of frequency of consumption, ordinal data from seafood FFQ were 
transformed to numerical data using the seafood-index system which has been explained 
by(Markhus, Graff et al. 2013).  
[2] To avoid double reporting on sushi consumption and to specify the amount of fish that 
contains, it was decided to weigh the amount of fish in a portion of sushi (between 6 – 10 bits) 
composed of nigiri and sushi rolls (maki) from three different seafood processing companies 
(Tradisjonell Sushi, Sushi Premium and Lerøy). The results showed that a portion of sushi can 
contain up to 25% of fish and this result was used in the seafood index. 
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[3] Simultaneously, it was developed a weekly index for milk-and dairy products and eggs 
consumption (Table 3-4). 
Table 3. Milk and dairy products index – conversion of frequencies to numerical values 
Reported Frequency Numerical interval per week Index 
one time per day 7 7 
two to three times per day 14 – 21 14 
four to five times per day 28 – 42 35 
seven to nine times per day 49 – 63 56 
ten or more times per day 70 70 
 
 
Table 4. Eggs index – conversion of frequencies to numerical values 
Reported Frequency Numerical interval per week Index 
less than one egg per week 0 – 0.25 0.15 
one egg per week 1 1 
two to three eggs per week 2 – 3 2.5 
four to five eggs per week 4 – 5 4.5 
six to seven eggs per week 6 – 7 6.5 
eight or more eggs per week  8 8 
 
[4] In addition, it was elaborate a list of equivalent weights and measures 
(kostholdsplanleggeren, NorwegianFoodSafetyAuthority et al. 2014) of the named food 
products in the FFQ to calculate iodine contain. The iodine content in supplements was 
calculated from the nutrition facts labels and personal communication with the distribution 
companies. 
The daily iodine intake from milk-and dairy products, eggs and supplements were calculate 
first by using the corresponding product index (milk and dairy products, eggs and 
supplements) divided by seven (the number of days in a week) and the results was multiplied 
by the equivalent weight of the food product and then, the results were multiplied by the 
amount of iodine contained in the food and divided by 100. The iodine intake from seafood 
was calculated by multiplying the reported portion size by the equivalent weight of the food 
product and the results were multiplied by the amount of iodine contained in the food and 
divided by 100. The total iodine intake is the sum of the all results from each food product 
which were calculated. (Fig. 6). 
[6] The total weekly intake of Seafood for dinner was calculated multiplying the seafood 
index for the main question for dinner by the equivalent weight of the food product. 
 
16 
 
 
Figure 6. Assessment of the total iodine intake 
 
2.3 Determination of iodine in human urine spot samples 
2.3.1. Collection of Sample 
Pregnant women provided a non-fasting spot urine sample. The urine samples were collected 
from 1008 women. The nine well-baby clinics were Fjell, Frogner, Høylandet, Lørenskog, 
Namsos, Strindheim, Tromsø, Ulset and Østensjø. Laboratory results were fully delivered in 
September 2014. 
Urine samples were stored in cryo tubes and then, stored for each baby clinic in the same box 
in the freezer at minus 20˚C. Cryo tubes were labeled with the mother’s identity, date, time 
(hour) of sample collection and gestational age (week). Not all tubes were labeled or had 
completed information. Gestational age was reported in 929 tubes, time was reported in 612 
tubes and the date was reported in 987 tubes.  
Gestational age was re-grouped into weeks 1 – 16, 17 – 29, and 30 to delivery, corresponding 
to the first, second and third trimesters, respectively (Bauch, Meng et al. 1986, Glinoer, Nayer 
et al. 1990, Smyth, Hetherton et al. 1997, Brander, Als et al. 2003).  
To see the variation by timing of collection (Wang, Cogswell et al. 2013) the urine samples 
were re-grouped in concordance to the time when urine sample were collected (Table 5). 
Table. 5 Timing of spot urine collection 
Timing Hours 
Morning sample 08:30 and 12:30 
Afternoon sample 12:31 and 17:30 
Evening sample 17:31 and 23:59 
Overnight sample 04:00 and 12:00 
 
Urine samples were also re-grouped according to the season of the year they were taken: 
Spring (5 Feb – 6 May), Summer (7 May – 6 Aug), Autumn (7 Aug – 16 Nov) and Winter (17 
Nov – 5 Feb). 
A laboratory technician performed all analyses. The master student was responsible for 
sample preparation after a theoretical and practical introduction. 
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2.3.2. Procedure for determination of iodine in urine sample 
All sample preparation and analysis of iodine in human urine was performed according to the 
method under development by the staff at NIFES. Iodine was determined using inductively 
coupled mass spectrometry ICP-MS (Agilent Technologies 
Inc. 
, Tokyo, Japan) (Julshamn, 
Dahl et al. 2001). 
Prior to analysis, the urine samples were defrosted in a refrigerator the day before. The sample 
preparation was as follow: 500 μl of urine were diluted in 4.5 ml 1% TMAH  
tetramethylammonium hydroxide (10 ml 25% TMAH diluted in 1 l of distilled water from 
Millipore) and filtered by using a sterile syringe filter with a 0.45 mm pore size and a 10 ml 
syringe. Blank samples were prepared at the same time by using distilled water instead of 
urine. 
Approximately, three to four standard solutions were made by mixing small amounts from a 
random selection of the sample solutions of the same matrix (mixed sample). These solutions 
were prepared to elaborate a urine calibration curve to against the measured 
127
 I by taken out 
05-10-20-50-100-200 μl of 5 ml/ L standard iodine Spectrascan 998 ± 4μg/ L, Teknolab AS 
(50 μl of standard iodine diluted in 10 ml distilled water) diluted with urine mixture 
(thoroughly mixed samples) up to a total of 5 ml. Blank samples was always run together with 
the standard curve. 
The accuracy of the results was verified with the certified Standard Reference Material (SRM) 
-Seronorm 
TM
 Trace Elements Urine L-1 and L-2, SRM 2670a Toxic Elements in Urine 
(Table 6). The SRM bottle was reconstituted with 5 ml for Seronorm L-1, 2 and 20 ml for 
SRM 2670a. 
Table 6. List of the standard reference material and their values 
Standard Reference Material Analytical Value Acceptable Range 
Seronorm 
TM
 Trace Elements Urine L-1 84 μg/ L 72 – 96 μg/ L 
Seronorm 
TM
 Trace Elements Urine L-2 304 μg/ L 260 – 348 μg/ L 
SRM 2670a Toxic Elements in Urine 88,2 µg/ L 87,1 – 89,3 µg/ L 
 
 
2.3.4. Procedure to determination of creatinine in urine Sample 
The procedure was performed by technicians at NIFES. For the urinary creatinine 
determination, the urine samples prior to analysis were defrosted at room temperature and 
centrifuged (15 min, 2000 g). All sample treatment was automatic in the Maxmat carousel; 
samples (200 µL urine) were diluted 1:20 with distilled water and reagents added. 
Determination of creatinine was performed by a colorimetric enzymatic principle using 
MAXMAT PL II multidisciplinary diagnostic platform (Maxmat S.A., Montpellier, France) 
using the creatinine PAP kit (personal communication Lisbeth Dahl). 
 
2.4 Measurement of iodine status 
Three measurements of iodine status were calculated from casual urine samples (Table 7). 
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Table 7. Methods for assessment iodine status 
Measurements Expression Reference 
Iodine concentration µg/ L  referred in several articles 
Iodine/ creatinine ratio µg I/ g creatinine (Barr, Wilder et al. 2005) 
Age- and sex-adjusted Iodine/ creatinine ratio Estimated I µg/ day (Knudsen, Christiansen et al. 2000, 
Garde, Hansen et al. 2004) 
 
The UIC was assessed on casual urinary samples and expressed as median value. The 
correction of the urinary volume in the mothers was calculated by using a sample iodine to 
creatinine ratio (Andersen 2008) (Formula 1). 
Iodine/ creatinine ratio = 
Iodine (µg/ L) 
Creatinine (g/ L) 
 
Considering that there was only one spot – urine sample available, it was decided to adjusted 
age and sex to creatinine ratio to estimate daily UIE and reduce the intra individual coefficient 
of variation in daily urine volume. The method seems to be better compared to non-adjusted 
iodine concentration and iodine/ creatinine ratio (Ovesen and Boeing 2002, Konig, Andersson 
et al. 2011). (Formula 2) 
Age- and sex-adjusted Iodine/ creatinine ratio = 
Iodine (µg/ L) * Expected creatinine (g/ day) 
Creatinine (g/ L) 
 
The expected creatinine excretion for pregnant women according to the literature was 1.09 g/ 
day (Pedersen, Borlum et al. 1988, Andersen, Moller et al. 2014).  
2.5 Sociodemographic questionnaire 
The general questionnaire collected details on participant age, smoking habits, self-reported 
anthropometric measures (weight prior to the pregnancy and current weight) to calculate the 
body mass index (BMI) (Formula 3), education, pregnancy-related concerns, uses medication 
and economic income and employment and marital status. 
Body Mass Index (BMI) = 
Weight (Kg) 
Height (m 2) 
 
2.6 Statistical analysis 
The present thesis is based on descriptive statistics. For quantitative variables, means, median, 
min and max values, standard deviations, percentiles and percentage were calculated. 
Qualitative variables were presented in contingency tables. All statistical analyses were 
performed using IBM SPSS Statistics 22 (originally Statistical Package for the Social 
Sciences). The various figures were made using SPSS and Microsoft Excel 2010. Due to the 
characteristics of the gathered data Pearson’s Correlation Coefficient was employed. The 
level of significance was set at p < 0.05 and p < 0.01.   
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3. RESULTS 
3.1 Descriptive characteristics of the study population 
A total of 1041 pregnant mothers were recruited to the study. Table 8 shows descriptive 
characteristics of the 1036 included pregnant women in the LiN study. 
Table 8. Socio-economic, behavioral characteristics and anthropometric measurements of study participants in LiN* (n= 1036) 
Characteristics Mean ± SD (min, max) Count (n) Percent (%) 
  n = 828  
Age                      (years) 29 ± 5 (17, 43)   
Height                       (m) 1.67 ± 0.06 (1.30, 1.84)   
Current weight       (kg) 72.92 ± 13 (50, 185)   
Prior weight            (kg) 66.26 ± 12 (42, 158)   
Current BMI    (kg/ m2) 26 ± 4.5 (17.30, 65.62)   
Prior BMI~       (kg/ m2) 23 ± 4.2 (16.80, 48.77)   
    
BMI Category (current)  n = 828  
Underweight (< 18.5)  2 1 
Normal (18.5 – 24.9)  375 45 
Overweight (25 – 29.9)  325 39 
Obese Class I (30 – 34.9)  92 11 
Obese Class II (35 – 39.9)  25 3 
Obese Class III (> 40)  9 1 
    
BMI Category (prior)  n = 828  
Underweight (< 18.5)  33 4 
Normal (18.5 – 24.9)  567 68 
Overweight (25 – 29.9)  154 19 
Obese Class I (30 – 34.9)  50 6 
Obese Class II (35 – 39.9)  16 2 
Obese Class III (> 40)  8 1 
    
Education   n = 884  
Lower secondary school  42 5 
Higher secondary school  249 28 
< 4 years of university education† 265 30 
≥ 4 years of university education† 328 37 
    
Employment  n = 1036  
Full-time (80 – 100%)  801 77 
Part-time (50 – 79%)  60 6 
Part-time (< 50%)  17 2 
Student   60 6 
Student and employee  60 6 
Other   38 4 
    
Marital Status   n = 1036  
Married   375 36 
Cohabiting  619 59 
Single  26 3 
Other   16 2 
    
Own Income in NOK‡  n = 1036  
< 1,50,000  122 12 
1,50,000 – 2,99,999  201 19 
3,00,000 – 4,49,999  460 44 
4,50,000 – 5,99,999  177 17 
≥ 6,00,000  76 7 
    
Self-reported smoking/ using of snuff during pregnancy n = 245  
Non-smoker/ non-user  238 97 
Current smoker/ current user 7 3 
    
Focus on Healthy Diet  n = 245  
Very small  2 0.2 
Small  17 2 
Medium  355 43 
High  375 45 
Very high  78 9 
†University or University College   
‡1,00,000 NOK 14,000 EUR 
~Before pregnancy 
*Little I Norway 
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3.2 Urinary creatinine 
At t1, gestational age was registered in 944 when the spot urine samples were collected. 
Gestational age was then grouped into three trimesters. Level of creatinine by trimesters I 
given in Figure 7. Mean level ± SD of creatinine were 1.3 ± 0.7, 1.2 ± 0.8 and 1.1 ± 0.6 g/ L 
for the first, second and third trimester respectively. Mean creatinine level from all samples 
was 1.24 ± 0.7 g/ L (median 1.1). 
 
Figure 7. Creatinine (g/ L) in spot urine samples in pregnant Norwegian women distributed 
by trimesters (n = 944) 
 
Box plot details: the horizontal line indicates the median; the box indicates the interquartile 
range (IQR) (IQR: 25
th
 percentile to 75
th
 percentile); the whiskers indicates observations 
within 1.5-times the IQR; the circles indicate observations more than 1.5-times the IQR away 
from the box, considered as outliers and the star indicate a score greater than the upper 
quartile plus 3 times the IQR which is labeled as extreme case (Field 2013). 
3.3 Urinary iodine and iodine status 
Table 9 shows Median urinary iodine concentration (MUIC) for pregnant women.  
Table 9. Urinary iodine concentration in pregnant Norwegian women 
 
 n= Median (min, max) P25
†
 P75
†
 Mean ± SD 
PREGNANCY SAMPLES  
           
-Iodine µg/ L 1008 82 4 774 48 135 105 90 
-µg I/ g cre 1006 75 5 1784 49 114 98 89 
-Estimated I µg/ day 1006 82 5 1944 53 123 106 97 
†P25 = 25th percentile, P75 = 75th percentile. 
µg/ L = microgram per liter;  g = gram; cre = creatinine; SD = Standard Deviation 
 
21 
 
According with the cut off values for pregnant women established by WHO/UNICEF/IGN 
(Table 1) approximately 80% of pregnant women had an insufficient iodine level, 20% had 
an adequate iodine level and 1% had excess (Fig. 8). Figure 9 shows the same prevalence 
based on severity of iodine deficiency (mild: 50 – 99 µg/ day, moderate: 20 – 49 µg/ day, and 
severe: < 20 µg/ day) (Travers, Guttikonda et al. 2006) 
 
Figure 8. Prevalence of iodine status in pregnant Norwegian women given as: iodine 
concentration (µg/ L) (n = 1008), iodine/ creatinine ratio (µg I/ g creatinine) (n = 1006) and 
age- and sex-adjusted iodine/ creatinine ratio (estimated I µg/ day) (n = 1006) 
 
 
Figure 9. Prevalence of severity of iodine deficiency in pregnant Norwegian women given 
as: iodine concentration (µg/ L) (n = 1008), iodine/ creatinine ratio (µg I/ g creatinine) (n = 
1006) and age- and sex-adjusted iodine/ creatinine ratio (estimated I µg/ day) (n = 1006) 
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3.4 Frequency food questionnaire 
At t1 833 women filled out the FFQ which revealed that almost every pregnant women 
included seafood, milk-and dairy products and eggs in the diet. Although the iodine rich food 
groups were included in their diet, frequency of consumption varied. Only 118 pregnant 
women reported to use iodine-containing supplements. 
3.4.1 Seafood intake 
At t1, 833 women reported the frequency of seafood intake for dinner. The estimated mean 
seafood intake was 1.3 ± 0.9 times per week (median 1.0). Figure 10 shows the frequency of 
seafood consumption as dinner. The median and mean seafood intake for dinner was 150 g 
per week and 29 g/ day (median 21), respectively. A total of 824 pregnant women reported 
the most preferred portion size at dinner: half portion is preferred for the 2% of the women, 
54% preferred 1 portion, 20% preferred one and a half portion and 3% preferred two or more 
than two portions. 
 
Figure 10. Frequency of intake of Seafood for Dinner given as percent of total numbers of 
pregnant Norwegian women (n = 833) 
 
 
 
Details about the type of seafood for dinner were reported in 822 pregnant women (Fig. 11). 
Oily fish represent the 37% of the fish consumption for dinner with an estimated mean of 0.5 
± 0.6 times per week (median 0.4).  Lean fish was consumed by 27% of the pregnant women 
with an estimated mean intake of 0.4 ± 0.5 times per week (median 0.3). Processed fish was 
consumed at dinner by 26% of the pregnant women with an estimated mean of 0.4 ± 0.4 
(median 0.4). Freshwater, shellfish and sushi was consumed at dinner for 10% of the women.  
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Figure 11. Distribution (%) of consumption of seafood for dinner in pregnant Norwegian 
women (n = 822) 
 
Consumption of seafood as spread was also evaluated in 833 pregnant women (Fig. 12) and it 
showed that 59% ate < 1 – 3 times per month or never, 39% ate 1 – 5 times per week and only 
1% ate > 5 times per week. The estimated mean seafood intake as spread was 1 ± 1.2 times 
per week (median 0.5). 
 
Figure 12. Frequency of seafood as spread given as percent of total numbers of pregnant 
Norwegian women (n = 833) 
 
Frequency of consumption of seafood for dinner and as spread is detailed in Table 10 (n = 
831).  The most frequently reported intake of seafood for dinner was salmon/ trout in the oily 
fish group; cod in the lean fish group; shrimp in the shellfish group and fish cake in the 
processed group in a frequency of 1 – 3 times per month. In the same frequency per month, 
sushi was consumed by 20% of the women. Freshwater fish was consumed < 1 time per 
month. More than 90% of the participants chose not to consume herring, redfish, perch/ pike, 
char/ powan or lobster.  
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Seafood as spread listed in the FFQ is primarily oily fish. 88% of pregnant women preferred 
oily seafood as spread while 12% preferred lean seafood. The estimated mean intake for oily 
and lean seafood as spread were 1.3 ± 1.5 times per week (median 1) and 0.2 ± 0.3 times per 
week (median 0.1) respectively. Figure 13 shows the type of oily seafood products which 
were most consumed between the participants and the prevalence of lean seafood products as 
spread.  
 
Figure 13. Distribution (%) of seafood consumption as spread (oily and lean) in pregnant 
Norwegian women (n = 716) 
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Table 10. Frequency of seafood intake in pregnant Norwegian women (n = 831) 
 Count (n) and percent (%) is shown† 
 
 never < 1 time/ month 1-3 times/ month 1-2 times/week ≥ 3 times/week 
SEAFOOD FOR DINNER          
OILY (> 5%) n % n % n % n % n % 
           
-Salmon/ Trout 86 10 127 15 403 48 206 24 9 1 
-Mackerel 603 72 96 11 90 10 34 4 8 1 
-Herring 771 92 45 5 13 1 2 0.2 0 0 
-Halibut 573 69 195 23 58 7 5 0.6 0 0 
           
LEAN (< 5%)           
-Redfish 762 91 55 6 14 1 0 0 0 0 
-Catfish 666 80 122 14 40 4 3 0.4 0 0 
-Flounder/Plaice 694 83 92 11 42 5 3 0.4 0 0 
-Cod 202 24 220 26 330 39 78 9 1 0.1 
-Saithe 469 56 185 22 143 17 34 4 0 0 
-Haddock 754 90 53 6 18 2 6 0.7 0 0 
           
FRESHWATER           
-Perch/ Pike 817 98 14 2 0 0 0 0 0 0 
-Char/ Powan 797 95 29 4 5 1 0 0 0 0 
           
SHELLFISH           
-Shrimp 317 38 245 29 236 28 31 3 2 0.2 
-Crab 692 83 108 13 29 3 2 0.2 0 0 
-Lobster 769 92 56 6 5 0 1 0.1 0 0 
-Blue Mussel 720 86 86 10 22 2 3 0.4 0 0 
-Scallop 699 84 102 12 29 3 1 0.1 0 0 
           
SUSHI 510 61 125 15 168 20 28 3 0 0 
           
PROCESSED           
-Fish Cakes 223 26 203 24 337 40 65 7 3 0.4 
-Fish Ball 367 44 191 23 235 28 36 4 2 0.2 
-Fish Pudding 554 66 140 16 114 13 23 2 0 0 
-Fish au gratin 309 37 204 24 281 33 36 4 1 0.1 
-Fish Sticks 478 57 176 21 151 18 26 3 0 0 
-Fish Soup 414 49 231 27 172 20 12 1 2 0.2 
-Clip Fish 741 89 73 9 17 2 0 0 0 0 
           
SEAFOOD AS SPREAD           
OILY (> 5%)           
-Mackerel in tomato 315 37 101 12 182 21 175 21 58 6 
-Canned Sardine 795 95 19 2 13 1 2 0.2 2 0.2 
-Canned Salmon 771 92 30 4 21 2 7 0.8 2 0.2 
-Brisling 825 99 4 1 1 0 1 0.1 0 0 
-Anchovies 784 94 29 3 13 1 5 0.6 0 0 
-Smoked Salmon/ cured Trout 503 60 123 14 150 18 48 5 7 0.8 
-Marinated Salmon/ Cured Trout 774 93 30 3 23 2 3 0.3 1 0.1 
 -Herring 733 88 50 6 29 3 16 2 3 0.3 
-Caviar 435 52 58 6 149 17 131 15 58 6 
-Patty (“svolværpostei”) 822 98 8 1 0 0 1 0.1 0 0 
-Patty (“lofotpostei”) 828 99 3 0.3 0 0 0 0 0 0 
           
LEAN (< 5%)           
-Shrimp  376 45 177 21 211 2 61 7 6 0.7 
-Tuna‡ 650 78 93 11 70 8 16 1 2 0.2 
-Crabsticks 747 89 46 5 28 3 9 1 1 0.1 
†Answers from the question “other seafood” were not included in this table. 
‡Tuna in water 
 
In the question “other seafood” the participants were asked to fill in the name of the seafood 
they had eaten. The following seafood was given: stock fish, pepper smoked mackerel 
(vacuum packing), scampi, liver pate, crayfish, octopus, pangasius (n = 14). Some other 
participants named a seafood product which was already listed in the FFQ (n = 46).  
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3.4.2 Milk-and dairy products intake 
The majority of pregnant women who completed the FFQ consumed milk-and dairy products 
2 – 3 times per day (68%) (Fig. 14). No one consume milk ≥ 10 times per day. The estimated 
mean milk-and dairy products frequency intake was 2 ± 0.6 times daily (median 2.0). 
 
Figure 14. Frequency of milk-and dairy products intake given in percent of total numbers 
of pregnant Norwegian women (n = 793) 
 
3.4.3 Egg intake 
The frequency of egg intake was mainly 2 – 3 eggs per week (39%) (Fig. 15). The estimated 
mean egg intake was 2.6 ± 0.1 times per week (median 3.0). 
 
Figure 15. Frequency of egg intake given in percent of total numbers of pregnant 
Norwegian women (n = 831) 
15 
68 
16 
1.1 
0
10
20
30
40
50
60
70
80
1 time/day 2-3 times/day 4-6 times/day 7-9 times/day
P
re
va
le
n
ce
 (
%
) 
Frequency 
16 
31 
39 
12 
2 
0.3 
0
5
10
15
20
25
30
35
40
45
< 1 egg/week 1 egg/week 2-3 eggs/week 4-5 eggs/week 6-7 eggs/week ≥ 8 eggs/week 
P
re
va
le
n
ce
 (
%
) 
Frequency 
27 
 
3.4.4 Multivitamin and mineral supplement: 
The frequency of multivitamin and mineral supplement intake is showed in Table 11. At 
inclusion of 343 of the 1036 women answered the question about the use of supplements. The 
list of supplements was re-grouped in this thesis into non-iodine-containing and iodine-
containing supplement. Most of the participants did not use the supplements given in the 
questionnaire. A total of 118 participants used iodine-containing supplement. 
Table 11. Frequency of multivitamin and mineral supplement intake in pregnant Norwegian women (n = 343) 
Count (n) and percent (%) is shown† 
 
 never 1-3 times/ month 1-3 times/ week 4-6 times/ week daily 
NON IODINE-CONTAINING SUPPLEMENT  
 n % n % n % n % n % 
           
-Møllers Tran 172 50 20 6 26 8 31 9 94 27 
-Møllers Dobell 316 92 8 2 4 1 2 1 13 4 
-Krillolje 343 100 0 0 0 0 0 0 0 0 
-Selolje 342 100 0 0 0 0 1 0 0 0 
-Complete Folat og Omega-3 342 100 1 0 0 0 0 0 0 0 
-Møllers Omega-3 + Folat 340 99 1 0.5 0 0 0 0 1 0.5 
-Gevita Omega-3 med Kalsium, 
vitamin D og K 
342 100 0 0 0 0 0 0 1 0 
-Trippel Omega-3 339 98 2 1 1 0.5 0 0 1 0.5 
-Multi-tabs GraviOmega 342 100 0 0 1 0 0 0 0 0 
           
IODINE-CONTAINING SUPPLEMENT  
-Lifeline Gravid 326 95 3 1 3 1 3 1 8 2 
-Lifeline Ammende 335 98 0 0 1 0 3 1 4 1 
-Nycomed Gravid 340 99.5 1 0.5 1 0.5 0 0 1 0.5 
-Nycopluss Omega-3 335 98 1 0 1 0 2 1 4 1 
           
Other Supplement 322 94 3 1 2 1 0 0 16 4 
†Answers from the question “other supplement” were included in this table and will be explained below. 
 
In the question “other supplement” the participants were asked to fill in the name of the 
supplement they had used. The following supplements were given for 19 mothers: arctic cod 
liver oil, «linfrøolje», «sanasol», «lofot tran» - capsules, efanatal – capsules, okinawa omega 
3,6,7,9, udo's choice omega 3,6, eye q liquid, «naturlig omega 3», «nycoplus tran», 
«multivitaminer med mineraler», omega cure, super food omega 3,6,9, «havfruenes tran», 
«jomfrueolje». 
The FFQ had also another open ended question “other supplement – vitamins and mineral”.  
The following non-iodine-containing supplements were given for 35 mothers: «pluss 
multivitaminer», «floradix», pregnant care multivitamin, «berocca», «biovit», life 
multivitamin, «sanasol», «collett kostpluss multivitamintilskudd», «collet 
multivitaminbjørner», spectra vitaminer, «vitaminbjørner», «nycoplus aktiv med 
magnesium», cederroth multivitamin. In the other hand; iodine-containing supplements were 
given for 114 mothers: «gravitamin», prenatal nutrients, «gevita», «kelp», «møllers total», 
«nycoplus omega 3 multi», «nycoplus multi uten vit A og D», «lifeline care gravide og 
ammende», «vitaplex», «nycoplus», «lifeline care for gravide», «nycoplus multi».  
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It was also considered to show the MUIC using the first estimate: Iodine Concentration (µg/ 
L) in consumers and non-consumers of seafood and milk-and dairy products according to the 
frequency of consumption (Figs. 16, 17) and users and non-users of iodine-containing 
supplement (Fig. 18). The following Figs. 16-18 show the cut-off value for insufficient iodine 
status during pregnancy (< 150 μg/ L) modified from(Bath, Walter et al. 2014).  
MUIC was 82 µg/ L and 78 µg/ L for seafood consumers (n = 824) and non-seafood 
consumers (n = 9) respectively (Fig. 16).  
 
 
 
Figure 16. Median urinary iodine concentrations of non-seafood consumers (n = 9) and 
seafood consumers (n = 824) according to frequency of seafood intake 
 
 
 
 
 
 
MUIC was 87 µg/ L and 49 µg/ L for milk-and dairy product (n = 793) and non-milk-and 
dairy product (n = 38) consumers respectively (Fig. 17).  
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Figure 17. Median urinary iodine concentration of non-milk-and dairy product consumers 
(n=38) and milk-and dairy product consumers (n= 793) according to frequency of milk-and 
dairy product intake  
 
MUIC was 101 µg/ L and 79 µg/ L for iodine-containing supplement users (n = 118) and non-
user of iodine-containing supplement (n = 687) respectively (Fig. 18).  
 
Figure 18. Median urinary iodine concentration of supplement users (n=805); iodine-
containing supplement users (n= 118) and non-user of iodine-containing supplement (n= 687) 
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3.5 Total iodine intake 
The total iodine intake is the sum of the intake of seafood, milk-and dairy product, egg and 
the use of iodine-containing supplements. The mothers who reported iodine-containing 
supplement in the question: “other supplement – vitamins and mineral” were not considered 
in this calculation due to the lack of information on the frequency of intake. The total median 
iodine intake from food and supplements was calculated to be 153 µg/ day (n= 833). The 
estimated median iodine intake of 800 non-users of iodine-containing supplement was 153 
µg/ day (range: 4 - 383 µg); whereas the median iodine intake of 33 iodine-containing 
supplement users was 268 µg/ day (range: 70 - 595 µg). Iodine intake < 150 μg/ day were 
found in the 36% (n=297) of the pregnant women. Intake less than 100 μg I/ day was found in 
5% (n = 42) of participants. A higher intake more than 300 μg I/ day was revealed in 3% (n = 
21) of pregnant women including one woman with an intake over 500 μg I/ day. Furthermore, 
the study showed that none of the participants had an intake of iodine above 1 mg/ day (Fig. 
19) 
 
Figure 19. Total iodine intake of pregnant Norwegian women from foods and supplements 
given as percent in each category (n= 833) 
 
 
 
The participants were grouped by trimesters, timing and season the spot urine sample was 
taken and distributed by the three different estimates in order to estimate the MUIC for each 
group. The following Figs. 20-22 show the WHO cut-off value for iodine status during 
pregnancy (< 150 μg/ L). 
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Gestational age was registered at inclusion in 929 of the 1008 spot samples collected 
registered gestational age (92%). A total of 6%, 79% and 14% gave a urine sample at the first, 
second and third trimester, respectively (Fig. 20). 
 
Figure 20. Median urinary iodine concentration by trimesters given as: iodine concentration 
(µg/ L), iodine/ creatinine ratio (µg I/ g creatinine) and age- and sex-adjusted iodine/ creatinine 
ratio (estimated I µg/ day) in pregnant Norwegian women (n = 929) 
  
The time of collection of the spot urine was registered in 60% of the 1008 samples collected 
(n = 612). A spot urine sample from pregnant women was collected for 38% in the morning, 
36% in the afternoon, 11% in the evening and 15% in the overnight (Fig. 21). 
 
Figure 21. Median urinary iodine concentration by sampling time  given as: iodine 
concentration (µg/ L), iodine/ creatinine ratio (µg I/ g creatinine) and age- and sex-adjusted 
iodine/ creatinine ratio (estimated I µg/ day) in pregnant Norwegian women (n =612) 
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The date of the spot sample collection was registered in the 98% (n = 987) of the 1008 
pregnant women which gave a spot sample. According to the distribution, 25% of the women 
gave a spot sample in winter, 26% in spring, 19% in summer and 30% in winter (Fig. 22). 
 
Figure 22. Median urinary iodine concentration by sampling season given as: iodine 
concentration (µg/ L), iodine/ creatinine ratio (µg I/ g creatinine) and age- and sex-adjusted 
Iodine/ creatinine ratio (estimated I µg/ day) in pregnant Norwegian women (n = 987) 
 
 
 
 
 
 
 
 
 
 
 
3.6 Statistical correlations 
For statistical analysis, only quantitative variables were considered. There was a significant 
correlation (p < 0.05) between MUIC and milk-and dairy products intake (R Pearson: 0.079 
and 0.075 for the 1
st
 and 2
nd
 estimate, respectively). 
There was a significant correlation (p < 0.01) between MUIC and gestational age (R Pearson: 
0.072 and 0.097 for the 2
nd
 and 3
rd
 estimate, respectively). 
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Table 12. Pearson's correlation between selected variables€ and the three different estimates 
iodine concentration (µg/ L), iodine/ creatinine ratio (µg I/ g creatinine) and age- and sex-
adjusted iodine/ creatinine ratio (estimated I µg/ day) 
    
    
 1
st
. Estimate   2
nd
. Estimate   3
rd
. Estimate  
 µg/ L   µg I/ g creatinine   Estimated I µg/ day  
         
 R Pearson P value n  R Pearson P value n  R Pearson P value n 
FFQ-variables            
1.Seafood for dinner           
Oily 0.024 0.504 794  0.010 0.779 767  -0.002 0.954 792 
Lean 0.039 0.271 794  0.048 0.185 767  0.010 0.775 792 
Freshwater -0.019 0.585 794  -0.031 0.393 767  -0.025 0.488 792 
Shellfish -0.002 0.955 821  -0.012 0.740 801  -0.007 0.850 824 
Sushi -0.009 0.811 794  -0.003 0.932 767  0.010 0.777 792 
Processed 0.020 0.582 794  -0.004 0.918 767  -0.055 0.122 792 
            
2. Seafood as Spread           
Oily 0.039 0.300 692  0.047 0.222 668  0.006 0.881 689 
Lean 0.029 0.446 692  -0.036 0.355 668  -0.019 0.610 689 
            
3.Milk-and dairy 
products 
0.079* 0.028 766  0.075* 0.043 739  -0.006 0.862 763 
            
4.Egg 0.003 0.938 803  0.023 0.528 776  -0.036 0.306 801 
            
5.Multivitamin 
and Mineral 
Supplement 
0.068 0.354 188  -0.052 0.483 181  0.114 0.117 190 
            
6. Total Seafood 
Index (1. +2.) 
0.073 0.320 188  0.099 0.185 181  0.034 0.643 190 
            
7.Combined variables           
Combined 6. +3. 0.073 0.330 180  0.094 0.221 173  0.020 0.791 181 
Combined 6. +4. 0.054 0.462 188  0.119 0.112 181  -0.038 0.603 190 
Combined 6. +5. 0.091 0.111 310  0.050 0.386 299  -0.029 0.616 309 
            
Another variable            
Gestational  
Week 
0.010 0.775 899  0.072* 0.031 895  0.097** 0.003 928 
*p < 0.05 (2 tailed)  
**p <0.01(2 tailed) 
€FFQ variables and Gestational week variable 
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4. DISCUSSION 
4.1 Methodological considerations 
4.1.1 Recruitment 
A total of 1041 mothers were enrolled in LiN study, but 1036 (99%) of them gave consent to 
keep the information and use the present results. The study had the collaboration of local 
health clinics which it is favorable in regard to the sampling of subjects used in the study 
(Lande, Andersen et al. 2000). The objective of LiN study was to have population-level 
results and not to link the mother with her survey results. This methodology may encourage 
respondents to be more sincere in their reply and have few concerns about exposure of the 
results (Kiesler and Sproull 1986). 
 
4.1.2 Exclusion criteria 
Exclusion criteria were not considered in this thesis. All women were included in this study. 
Reviewing the literature, some studies had excluded women who reported taking TH drugs 
(e.g., thyroxine) (Opsahl 2002, Travers, Guttikonda et al. 2006, Dorey and Zimmermann 
2008, Bath, Steer et al. 2013) or had any diseases related to the thyroid (Cobin, Gharib et al. 
2001, Sawka, Ibrahim-Zada et al. 2010). In healthy adults, the absorption of iodine is greater 
than 90% (IOM 2001 ) but if the mother has low levels of TH and therefore hypothyroidism, 
it could be assumed that the mother has already low iodine levels due to hypothyroidism is a 
disorder induced by ID (Delange 1994) and when thyroxine is orally administered, the iodine 
bioavailability is approximately 75% (IOM 2001 ). There was only one mother who reported 
taking levaxin which is used to treatment of hypothyroidism. Undiagnosed hypothyroidism in 
pregnant women is probably more prevalent than usually considered (Glinoer 1997) and it is 
possible that some women with thyroid disease were unrecognized. This mother was not 
excluded because one case will not affect the final results and the preexisting thyroid diseases 
do not influence UIC (Brander, Als et al. 2003). Further, the highest values in the spot urine 
sample were not excluded in this study as in The Avon Longitudinal Study of Parents and 
Children (ALSPAC) (UIC > 500 µg/ L). Although levels of iodine higher than 500 µg/ L 
could be statistical outliers it is not unusual to find such levels in the urine samples. 
  
4.1.3 Urinary creatinine 
Creatinine is normally excreted daily in urine in a relatively constant rate (Soldin 2002, Price, 
Newall et al. 2005). The study used urinary creatinine concentration to correct UIC for intra-
individual variation within the mothers and closely approximate iodine status in the whole 
group using the age-and sex-adjusted iodine/ creatinine ratio (Formula 2). The daily 
creatinine excretion was estimated to be 1.09 g/ day for the studied pregnant women aged 
from 17 to 43 years. The results (Table 9) showed no differences between iodine 
concentration (µg/ I) and the age-and sex-adjusted iodine/ creatinine ratio (estimated I µg/ 
day) as was expected and obtained in previous studies: 127 vs. 167 (Seldal 2012) and 85 vs. 
151 (Bath, Walter et al. 2014) for µg/ I and estimated I µg/ day respectively. One possible 
reason why these studies got higher values is because the expected daily creatinine excretion 
used was 1.23 g/ day (Knudsen, Christiansen et al. 2000) but for non-pregnant women. 
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Although some studies affirm that creatinine excretion values from non-pregnant women can 
be used as unaltered in pregnancy (Mojtahedi, de Groot et al. 2002), it was decided to use in 
this study, a creatinine excretion value from pregnant women used recently in Denmark (1.09 
g) which is also in accordance with a studied  conducted in Switzerland (1.0 g) (Brander, Als 
et al. 2003). 
 
Creatinine concentrations are also used to determine whether the spot urinary sample is valid. 
According to WHO, if a sample has a creatinine concentration < 30 mg/ dl or > 300 mg/dl, 
another urine void should be collected (Barr, Wilder et al. 2005).  One limitation of this study 
is that all creatinine spot samples from the phase t1 were used without first determining the 
creatinine concentration. This determination was done, after creatinine samples were analyzed 
and there were 78 (25 too diluted and 53 too concentrated) samples which should have been 
discarded (data not shown).  
 
This study also shows the mean urinary creatinine concentration (g/ L) by trimesters (Fig. 7). 
To our knowledge, no study has shown this type of results in urine for comparison purposes. 
The values from a spot sample may vary from 0.4 to 1.4 g/ L in non-pregnant women 
(Surgery 2001). 
4.1.4 Seafood-FFQ 
The FFQ was completed for the 80% of participants which means that even if the 
participation in LiN study was voluntary, the response rate was very good (Baruch and 
Holtom 2008). The measurement of dietary habits during pregnancy are difficult due to 
metabolic and physiological changes in appetite, eating patterns, myths and beliefs on some 
type foods (Meltzer et al. 2008, Pinto, Severo et al. 2010, Brantsæter, Abel et al. 2013). 
However, this FFQ does not intend to measure the whole diet (Seldal 2012). 
An association between maternal diet and health outcomes require a valid tool to accurately 
measure the diet (Pinto, Severo et al. 2010). This study used a short semi-quantitative FFQ 
(portion size of a list of food items is included) to measure diet in pregnant women and it is 
adequate to estimate long-term iodine intake (Willett, Sampson et al. 1988, Ortiz-
Andrellucchi, Doreste-Alonso et al. 2009).  The FFQ collected the information for the last 
three months, which must be the most trusted in this kind of studies (Rasmussen, Ovesen et 
al. 2001). A FFQ is easy to  administer in large and geographically widespread samples 
(Cade, Thompson et al. 2002, Willett 2013) and is less time-consuming in comparison with 
other dietary methods (Brantsaeter 2007). 
The women were asked to fill in the self-administered FFQ using a web access sent by e-mail 
address. The data were transformed of raw data into computer-readable form (Kiesler and 
Sproull 1986). Electronic questionnaires are more complete with fewer mistakes (Kiesler and 
Sproull 1986) within a few days (Sheehan 2001). The mothers had to fill in all questions 
before they were allowed to finish the FFQ. Although there is not interviewer to ask in the 
case of any misunderstanding and the women may not be motivated enough to complete the 
whole questionnaire (Reja, Manfreda et al. 2003); the FFQ do not require trained personnel 
and can be self-administered (Barrat, Aubineau et al. 2012). Moreover, the time used to 
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complete the FFQ was not measured, but it is supposed to be 15 minutes. Questionnaire 
length could or not influence response in the whole questionnaire or any questions (Herzog 
and Bachman 1981, Sheehan 2001). 
The FFQ had multiple choice questions (e.g. Appendix: SjoT1_5, SjoT1_6). These kind of 
questions often are easier to answer, require less of the respondents' time, permit direct 
quantification of answers (Johnson, Sieveking et al. 1974) and reduce errors compared to 
open-ended questions (Subar, Thompson et al. 1995). However, multiple choice questions are 
often supplemented with open-ended questions in order to obtain clear answers (Johnson, 
Sieveking et al. 1974). The question “other seafood” (Appendix: SjoT1_6a) was not specified 
but the intention was to obtain the consumption of fish as a spread. It would have been better 
to place an open-question after each multiple choice question to reinforce the results. 
Increasingly detailed questionnaires decrease the information obtained (Willett 2013) as 
shown in Table 10 and Table 11 where many of the women choose “never”. Many reasons 
can justify this result (i.e. mothers decrease fish consumption during pregnancy, mothers did 
not find the fish consumed in the list or they just chose this option (Herzog and Bachman 
1981)). However, the result shown in that table is due to an error in the electronic 
questionnaire which made that the participants could not answer the questions (personal 
communication, Marian K. Malde).  
Open-ended questions are useful to explore given responses in the close-ended questions. A 
drawback is the use of an extensive coding before the actual analysis can take place (Reja, 
Manfreda et al. 2003). The total number of iodine-containing supplement users was calculated 
using the open-ended question “other supplement – vitamins and mineral” (Appendix: 
SjoT1_9e3). However, the amount of iodine coming from those supplements was not possible 
to calculate in some mothers from this open-ended question because the frequency of intake 
was not reported. Open-ended question produce more missing data than close-ended question 
(Reja, Manfreda et al. 2003). 
The present study calculated total iodine intake (μg) from the FFQ based on frequency, 
portion size (Appendix: SjoT1_2) and iodine content in the food and in the supplement. Only 
the amount of iodine intake from fish as dinner was taken into account to achieve this 
calculation. The amount of iodine from seafood as spread was not calculated due to several 
factors: [1] The FFQ contains 15 specific items on seafood consumption as a spread 
(Appendix: SjoT1_6). Extensive detailed interrogation is susceptible to overestimation 
(Tjonneland, Overvad et al. 1991) and could be over reported (Willett and Lenart 1990). [2] 
The FFQ does not give information about the portion size of the spread. In theory a portion 
size of seafood as spread is 25 g (TheNorwegianDirectorateofHealth 2011) but the correct 
amount the women chose to eat lunch was difficult to estimate. [3] The FFQ does not include 
the daily frequency of seafood consumed as a spread.  
A challenge was to calculate the iodine intake from milk-and dairy products. The FFQ had 
only one general question about the daily frequency of intake of milk-and dairy products 
(Appendix: SjoT1_8b1) given as one glass of milk, one cup of yogurt or a portion of cheese. 
Therefore, it was not possible to determinate what type which had been consumed. However, 
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according to the nationwide food consumption survey conducted in Norway - Norkost 3 
(Totland 2012) women with high education level have a higher consumption of milk than 
cheese and therefore; the author of this thesis assumed that the answers given in the 
questionnaire refer principally to the frequency of milk consumption. The limited information 
obtained from this question leads the author to conclude that the question should be improved 
and more explicit about the frequency and the portion size for each dairy product. This 
limitation may have underestimate the results of total iodine intake (e.g. one portion milk 
contains ~16 μg I but one portion whey cheese contains ~26 μg I (Dahl, Johansson et al. 
2004)). Inaccurate portion sizes and food specification limit the quantity of intake (Biro, 
Hulshof et al. 2002). 
Traditionally a FFQ is combined with food composition tables to calculate intake of specific 
nutrients (Wild, Andersson et al. 2001, Combet and Lean 2014) since the iodine content of 
food is varied and the values are not always available (Bath, Jolly et al. 2013). To calculate 
the total iodine intake; the food weights (gram per day) were multiplied by the nutrient value 
per 100 g of food using the amount of iodine in food, estimated in previous studies developed 
at NIFES (Dahl, Johansson et al. 2004) which are in accordance with the new version of the 
food composition table 2014 in Norway.  
The FFQ did not include any question about the use of table salt or use of iodine fortified salt. 
The consume of drinking water was not considered possible because it’s non-significant 
amounts of iodine (~2 μg/ L) in Norway (Dahl, Johansson et al. 2004). 
4.2 Discussion of results 
4.2.1 Descriptive characteristics 
The average age was 29 ± 5 years (Table 8) and is within the range of the national average 
age (30.5) of women giving birth to children (Statistics and NorwayA 2013). The mean age 
reported in other Norwegian studies (Brantsaeter, Haugen et al. 2007, Haugen, Brantsaeter et 
al. 2008, Brantsaeter, Haugen et al. 2009, Brantsaeter, Haugen et al. 2010, Seldal 2012, 
Markhus, Graff et al. 2013) and in studies in other European countries (Limbert, Prazeres et 
al. 2010, Bath, Steer et al. 2013, Hynes, Otahal et al. 2013, Bath, Walter et al. 2014, Rydbeck, 
Bottai et al. 2014) also includes women within the same age range.  
 
It is known that iodine has an influence on both physical and mental development (Merkiel 
and Chalcarz 2011). Current BMI showed also that 39% of the women were overweighted 
and 15% were obese. Overweight and morbid maternal obesity is a risk factor for thyroid 
dysfunction in pregnant women in iodine-deficient areas (Gowachirapant, Melse-Boonstra et 
al. 2014). 
The education level was in accordance with MoBa study and higher than in the general female 
population of Norway (statistics and NorwayB 2013) and Norkost 3 (Totland 2012). Maternal 
education is positively associated with maternal iodine status (Bath, Steer et al. 2013) and 
higher seafood intake (Gallo, Jean-Philippe et al. 2010). It was not made any association 
between educational level and UIC in this thesis. 
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The percent of women working full-time was higher than in MoBa study (Meltzer, Brantsæter 
et al. 2008) and in accordance with the results showed by (Markhus, Graff et al. 2013). 
4.2.2 Urinary iodine  
The MUIC (82 µg/ L) (Table 11) classifies the pregnant women as iodine deficient. The 
median creatinine: ratio value is also low and the median age-and sex-adjusted iodine/ 
creatinine ratio value is not what was expected (i.e. 158 - 225 µg) (Bath, Walter et al. 2014). 
Taking into account that 90% of iodine is excreted in urine, a UIC of minimum 150 µg/ day 
indicates iodine sufficiency (Seldal 2012). However, only 17% have a UIC above this 
minimum value. Furthermore, even when the MUIC is adjusted by creatinine, age and sex; 
the results are still below the WHO criteria (Table 1) and a mild iodine deficiency is shown in 
almost half part of the group with a MUIC between 50 and 99 µg/ L (Fig. 9). The UIC is not 
valuable for individual assessment (IGN/UNICEF/WHO 2007) and therefore this degree of 
deficiency found in the study, should be interpreted with caution. 
 
The MUIC obtained in the present study are according to other studies reporting a high 
prevalence of borderline iodine deficiency in pregnant women worldwide with a UIC close to 
or below 150 µg/ L like the recent ALSPAC study in the UK (91 µg/ L), Australia, Spain, 
Australia, Portugal, Italy and Israel (Benbassat, Tsvetov et al. 2004, Travers, Guttikonda et al. 
2006, Marchioni, Fumarola et al. 2008, Alvarez‐Pedrerol, Ribas‐Fitó et al. 2010, Charlton, 
Gemming et al. 2010, Limbert, Prazeres et al. 2010, Murcia, Rebagliato et al. 2010, Fisher, 
Tran et al. 2011, Bath, Steer et al. 2013, Hynes, Otahal et al. 2013).  The iodine status in 
pregnant women in Norway is in contrast with Nederland (median UIC 229.6 µg/ L) 
(Ghassabian, Steenweg-de Graaff et al. 2014) and other countries like Japan and Switzerland 
(Brander, Als et al. 2003, Fuse, Ohashi et al. 2011) where the iodine status is adequate. The 
comparison of the results between these studies and our study indicate that Norway is a part 
of the European countries with inadequate iodine supply during pregnancy (Lazarus 2014).  
The IGN published the Global Iodine Nutrition Scorecard for 2014 and assume that Norway 
is an iodine sufficient country (IGN 2014). The results from this study, “The Fjell Study” and 
MoBa study; indicate that even if the general population have an adequate iodine intake, there 
is an inadequate iodine status in some sub-groups like pregnant women in Norway (Lazarus 
2014). The consequences of ID in this particular group should be more investigated to update 
our knowledge and thereby identify, optimize and maintain the optimal iodine status in the 
pregnant population (Andersson, de Benoist et al. 2007). 
 
4.2.3 Seafood intake 
According with the FFQ, only 30% of pregnant women met the Norwegian recommendation 
of 2 – 3 meals weekly (Fig. 10). Intake of fish 2-3 times a week, covers the normal need for 
iodine (TheNorwegianDirectorateofHealth 2011). Furthermore, the median seafood intake for 
dinner was 150 g per week and it is below the Norwegians Recommendations of eating 300-
450 g of fish weekly (TheNorwegianDirectorateofHealth 2011).  
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A mother who eats fish 3 times a week, eats 347 g fish per week (~50 g/ day) (Hibbeln, Davis 
et al. 2007). Maternal seafood intake lower than 340 g per week is associated with an 
increased risk of low verbal IQ score (Bath, Steer et al. 2013) and suboptimum 
neurodevelopment outcomes in the child (Hibbeln, Davis et al. 2007, Malde, Alvheim et al. 
2012). Almost the 70% of the participants who eat fish had a weekly intake lower than 375 g. 
The estimated mean intake of maternal seafood for dinner was 29 g/ day. This average is 
lower than in other Norwegian studies in pregnant women e.g. 42 g/ day (Brantsaeter, Haugen 
et al. 2010), 36 g/ day (Brantsaeter, Birgisdottir et al. 2012), a median of 32 g/ day (Markhus, 
Graff et al. 2013) and in other international studies e.g. 32 g/ day in Mexico (Parra, Schnaas et 
al. 2002), 47 g/ day in Iceland (Thorsdottir, Birgisdottir et al. 2004) and 34 g/ day in UK 
(Hibbeln, Davis et al. 2007). On the other hand, the estimated average in this study is higher 
than the 16 and 27 g/ day reported in pregnant women in Denmark (Olsen and Secher 2002, 
Halldorsson, Meltzer et al. 2007) or 21 g/ day in Boston, USA (Oken, Guthrie et al. 2013). 
The average seafood intake (g/ day) from all these studies appointed is the combined seafood 
intake for dinner and as a spread, while the result in this thesis only represents dinner. 
It was not possible to estimate quantitative intake (g) of seafood as a spread. Therefore, the 
total seafood intake (g/ week) is probably higher than 150 g weekly. However, it is still 
unlikely that these women reach the Norwegian recommendations even when including a 
spread, since the average frequency of seafood as a spread was one portion per week.  
Approximately six portions (25 g each) of spread are needed to replace one dinner portion 
(150 g) (TheNorwegianDirectorateofHealth 2011). 
According to Norkost 3, a Norwegian women aged from 18 to 79 years eat 56 g fish/ day 
(Totland 2012). Although this information; it is clear that Norwegian women have been 
shown to have lower consumption of seafood over the past decades (Johansson and Solvoll 
1999) and this increases during maternity. The reason is unclear. One possible reason is the 
geographical location.The seafood consumption is relatively high in coastal areas (Johansson 
and Solvoll 1999, Welch, Lund et al. 2002). A second possibility is the avoidance of certain 
fish species due to mercury exposure which decrease the total seafood consumption in ~1.4 
servings/ month (Oken, Kleinman et al. 2003). The Norwegian recommendations to pregnant 
women advise to limit the intake of large perch, wild trout and halibut and to not eat pike liver 
or exotic predatory fish like fresh tuna (TheNorwegianDirectorateofHealth 2009). 
Furthermore, the avoidance of certain fish in fear for damage the child is reported in 53% of 
the mothers (data not shown).A third possible reason is called the morning sickness (Kramer, 
Bowen et al. 2013). However, a Canadian study showed that most pregnant women feel relief 
by week 22 and the period lasts a month (Lacroix, Eason et al. 2000). In this study 70% and 
33% pregnant women reported nausea and vomiting respectively, before week 22 (data not 
shown). Additionally to these possible reasons; a study conducted in Belgium affirm that the 
seafood intake among women increases with increasing age but decreases in the maternity 
(Verbeke and Vackier 2005).  
Despite these possibilities; the seafood intake in pregnant women should be increased; not 
only due to the nutritional benefics, but also for the risk of preterm delivery and low birth 
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weight (Leventakou, Roumeliotaki et al. 2014) increased with a daily intake below 15 g fish 
(Olsen and Secher 2002). The lowest weekly intake in this study was 22.5 g fish.  
The Norwegian recommendations during pregnancy suggest to eat small portions, more often 
during the day (TheNorwegianDirectorateofHealth 2009). A possibility to increase the total 
seafood intake without affecting the dietary habits within the family is to increase the seafood 
consumption as a spread (Seldal 2012). In theory, if this group of women had increased the 
seafood intake as a spread, they would have reached the Norwegian recommendations. 
However, this theory may not be feasible in the whole group, due to physical and 
psychological factors, the fact that some women eat maximum three meals daily during 
pregnancy (Siega-Riz, Herrmann et al. 2001) and that the seafood intake as spread decrease 
(Malde, Alvheim et al. 2012). The possibility to increase seafood intake as spread is 
important, but it is even more important to promote and increase the frequency of seafood at 
dinner in pregnant women.  
Total oily and lean fish intake 
The total oily fish intake in the present study was higher compared to the Norkost 1997, the 
“Fish and Game Studyv” and the Norkost 3 (Johansson and Solvoll 1999, 
NorwegianScientificCommitteeforFoodSafety 2007, Totland 2012). However, these studies 
include participants in a broader age range. 
 
Assuming that the greatest consumption comes from oily fish, the median seafood intake for 
dinner was 150 g weekly and the median oily fish intake was once per week; it could be 
possible that the women have been reached the recommended 200 g of oily fish per week 
(TheNorwegianDirectorateofHealth 2011). However, it is a lean fish and processed fish 
(primarily of lean fish) (NorwegianScientificCommitteeforFoodSafety 2007) which contains 
more iodine than oily fish and in this study, total lean fish intake represents the third part of 
the total seafood intake. 
 
Oily fish intake delay spontaneous delivery and premature labor (Olsen and Secher 2002), 
but, lean fish have a greater benefit than fatty fish such as fetal growth during pregnancy 
(Oken, Guthrie et al. 2013). Lean fish intake has a positive association between infant birth 
weight and head circumference (Brantsaeter, Birgisdottir et al. 2012) and increases the iodine 
intake in the body.  
4.2.4 Milk-and dairy products intake 
Most women had a milk-and dairy products intake 2 – 3 times daily with a significant 
correlation with the MUIC. The MUIC among pregnant women varied with the frequency of 
the food, but the women who do not consume milk-and dairy products have lower MUIC than 
frequently consumers (Fig. 17). This result is in agreement with a recent study from UK 
among pregnant women also using a spot urine sample (Bath, Walter et al. 2014). On the 
other hand, a woman with more than 7 servings per day, have higher MUIC than the others. 
Higher milk and yogurt intake is needed to obtain 150 μg iodine daily (Brantsæter, Abel et al. 
                                                          
v
 Fisk- og viltundersøkelsen 1999 
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2013). These women with highest milk- dairy products intake had a median iodine intake of 
374 µg / day. 
Milk- and dairy products are an important source of iodine in Norway due to relative high 
consumption of them. Although it is assumed that the iodine requirements are covered in the 
Norwegian population due to the high dairy products intake; national studies have pointed out 
that the iodine content in these products is lower in summer than in winter months (Dahl, 
Opsahl et al. 2003) but without variations within the same season for the different types of 
milk (15 μg/ 100 g) (Dahl, Johansson et al. 2004). Despite this fact, it should note that a 
recent study in Norway found that the iodine content in milk from the winter season has been 
reduced to nearly the half during the last decade (Haug, Taugbøl et al. 2012). The iodine 
content in these food products must be analyzed and the information should be updated to 
supply an adequate iodine intake in the population and have an appropriate choice of foods 
which contain iodine. 
 
4.2.5 Egg intake 
A significant correlation between egg intake and MUIC was not found in this study. However, 
studies suggest a positive association between egg consumption and iodine status in pregnant 
women (Alvarez‐Pedrerol, Ribas‐Fitó et al. 2010, Bath, Steer et al. 2013, Bath, Walter et al. 
2014) despite the small amount eaten (Dahl, Johansson et al. 2004). 
 
4.2.6 Multivitamin and mineral supplement 
This study showed that only 14% of mothers were using a prenatal vitamin and mineral 
supplement contained iodine. The percent is lower than in a sub group of 119 women (19%) 
and in the total group of 61, 904 women (31.6%) in MoBa study (Brantsaeter, Haugen et al. 
2007, Brantsæter, Abel et al. 2013) and a study conducted in the UK (42%) with 100 women 
enrolled (Bath, Walter et al. 2014). All these studies used also a FFQ. Many reasons can 
justify this result.  
Studies suggest that only 13 – 50% of pregnant women in Europe receive an iodine-
containing supplement (Zimmermann and Delange 2004), and in Norway, the Norwegian 
Recommendations during pregnancy do not include use of iodine supplementation 
(Brantsæter, Abel et al. 2013). Adequate iodine through prenatal vitamins (Stagnaro-Green 
and Pearce 2013) among pregnant (no later than 4 – 6 weeks of gestation) (Leung, Pearce et 
al. 2013) and breastfeeding women is important due to the positive effects in the mother and 
fetus (Hynes, Otahal et al. 2013). Further, clinicians in European countries has pointed out a 
daily supplementation with ≥ 150 µg I/ day for a long period before conception to ensure 
plenty intrathyroidal iodine stores. 
Although there are no published data about iodine content in supplements in Norway, the 
author of the present thesis made some calculations based on the available supplements 
containing iodine in the Norwegian market and concluded that the most used supplements 
contain iodine in the range of 25 to 175 µg I/ tablet (median 150) unlike the stated by(Seldal 
2012)of 150 to 175 µg I/ tablet and by (Dahl 2003) of 50 to 200 µg I/ tablet. The range of 
iodine in the supplements reported by the participants in this study was lower than the range 
42 
 
reported in a recently study in UK (75 – 150 µg I/ tablet) maybe because the most consumed 
UK prenatal supplements brand does contain iodine (Bath, Walter et al. 2014). According to 
(Zimmermann 2010)most multivitamin/ mineral preparation contain iodine but that was not 
found in this study. On the contrary, it seems like the minimum amount of iodine in a tablet, 
has been declining over the years. 
This study showed that the MUIC in women taking iodine-containing supplements was higher 
than in non-users of iodine-containing supplement (Fig. 18) and this is in agreement with 
previous studies reported in Europe (Zimmermann and Delange 2004, Bath, Walter et al. 
2014) and within the country (Brantsaeter, Haugen et al. 2007). The use of iodine-containing 
supplements is important to supply adequate iodine for those who do not eat or have low 
intakes of seafood and/ or milk-and dairy products in their diet (Brantsæter, Abel et al. 2013). 
 
4.2.7 Total iodine intake 
In this study, the total median iodine intake from foods and supplements was 153 µg/ day and 
62% and 90% of pregnant women have a daily iodine intake below the Nordic 
Recommendations (Table 2) and the WHO/UNICEF/IGN recommendation of 250 µg/ day, 
respectively. These results showed that only a third part of this group has an adequate iodine 
intake and the WHO recommendation is difficult to achieve in Norway.  
An iodine intake < 150 µg/ day was shown in 35% of the women and the percentage was 
lower than in a sub group from MoBa study (Brantsæter, Abel et al. 2013). However, even if 
our group is still not in a risk for sub optimal intake like the mothers in MoBa study, it does 
not mean that the iodine intake is inadequate for the majority of pregnant women in this 
study. 
Fortunately, no one had the minimum intake of iodine of 70 µg/ day and an iodine excess was 
showed only in one woman who take 2 iodine-containing supplements 4 – 6 times per week. 
The use of supplements with iodine increases the total iodine intake in the person which is 
reflected in the highest values of MUIC in this study. 
Between users and non-users of iodine-containing supplement, the total median iodine intake 
was higher in the first group than in the another and above the Nordic recommendation. The 
non-users group did not reach the national recommendation and the total median intake is the 
same than in the whole group.  
4.2.8 Median urinary iodine concentration by trimesters 
The MUIC increased from the first to the third trimester of pregnancy through the three 
different estimates (Fig. 20) although there is a slight tendency for lower value in the second 
trimester (with median creatinine: ratio). A similar pattern was observed in other recently 
studies (Vila, Serra-Prat et al. 2011, Rydbeck, Bottai et al. 2014) but it should emphasize that 
the studies did not use the same criteria to define the trimesters. Otherwise, studies on UIC 
values through gestational weeks are not consensual (Brander, Als et al. 2003, Ainy, 
Ordookhani et al. 2007, Limbert, Prazeres et al. 2010). Moreover, MUIC observed in the third 
trimester is higher than the other, which is contradictory with the idea that during the first 
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trimester, the increases in renal iodine excretion elevate the UIC levels while the iodine 
excretion decrease with advancing gestation (Hynes, Otahal et al. 2013). These differences are 
probably due to the amount of iodine ingested, the initial thyroidal iodine store, degree of 
iodine deficiency or difference in the sample size (Fuse, Ohashi et al. 2011). Despite this 
result, a significant correlation between gestational week and MUIC was found in the study 
(Table 12). 
 
4.2.9 Median urinary iodine concentration by sampling time 
The MUIC varies with the time of day the spot sample was taken (Fig. 21). The urine sample 
was taken throughout the day and in non-fasting conditions. Some studies affirm that the 
iodine excreted during the day it is ingested, have peaks following the three main meals by 4 
– 5 hours (Soldin 2002, Busnardo, Nacamulli et al. 2006).  The time since last meal was not 
recorded by the health care personnel and could be a disadvantage to complete the objective 
of this thesis, but variability among MUIC and timing could have been avoided if the urine 
samples had been collected in fasting conditions (Thomson, Packer et al. 2001, Busnardo, 
Nacamulli et al. 2006).  
 
4.2.10 Median urinary iodine concentration by sampling season 
Season at urine collection (Fig. 22) showed that MUIC increase during spring and not on 
winter as was expected (on the basis that iodine concentration in milk-and dairy products 
which is the major source of iodine is higher on winter). A similar result was found in a study 
carried out in Denmark among adults (Rasmussen, Ovesen et al. 2002). It is known that UIC 
in spot samples can vary between seasons (Konig, Andersson et al. 2011, Amouzegar and 
Azizi 2013). However; there are few studies concerning the seasonal fluctuations of UIC 
values during pregnancy to explain and compare the results. 
 
4.3 Summary and conclusions 
In certain European countries such as Norway, the high seafood intake and milk-and dairy 
products have secured on the iodine status of the general population. However, there is 
increasing evidence that an inadequate iodine intake has re-emerged in some subgroups such 
as pregnant women. Adequate iodine supply from foods and supplements is required to avoid 
damage in the developing brain in the fetus and related thyroid diseases in the mother. The 
assessment of the iodine status either by measuring urinary iodine concentration or by 
estimating dietary intake is suitable methods which can be used for the general population. A 
maternal iodine deficiency has public health implications and therefore more studies are 
needed in order to establish a strategy against the consequences of ID in the mother and 
especially in the fetus. 
The results from this thesis show that: 
[1] The MUIC is 82 µg/ L and 80% of the women had an inadequate iodine status below the 
WHO criteria of 150 µg/ L. 
[2] The total median iodine intake from foods and supplements (153 µg/ day) was below the 
Norwegian recommendations of 175 µg/ day. 
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[3] Intake of milk-and dairy products and gestational age correlated significantly with MUIC. 
Findings in the present study from median UIC classify the pregnant women as iodine 
deficient. Estimated dietary iodine intake also shows inadequate iodine intake among the 
women. In conclusion, this study shows that the diet of the pregnant women does not secure a 
sufficient iodine intake and one strategy to increase the iodine intake could be to increase the 
seafood intake. 
4.4 Future perspectives 
The results from this thesis indicate that this group of women has an inadequate iodine intake. 
The possibility to further investigate the importance of the deficiency and how it will affect 
the growth and intellectual development of children is a point that should be considered in 
future studies. 
To assess the iodine intake, accurate and sensitive tools are needed. The new version of the 
Norwegian food composition table 2014 includes iodine levels from different food products. 
However, since the food on the markets may change or new products could be available, a 
regular collection of foods for determination of iodine is of importance. This monitoring of 
the food will contribute to make appropriate choice of foods high in iodine if iodine supply is 
needed. 
Furthermore, published data about the iodine content in supplements in Norway and the 
promotion of its use among women is required. When there is a low intake of dietary sources 
of iodine, an iodine-containing supplement may secure the iodine intake needed. Especially in 
pregnancy, an adequate supplementation even before pregnancy is advisable. Specifics dietary 
recommendations about iodine intake should be included in Norwegian food and diet 
recommendations. 
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6. Appendix - FFQ 
LIN WEB MOR 
 
Sendes inn hjemmefra 
 
Denne kommer til å gjøres om til hovedundersøkelsen som foreldrene via 
epostutsendelse sendes inn i ulike deler av på ulike tidspunkt. 
 
login_velkommen 
webskjema - Velkommen til Liten i Norge studien. 
Hvilken undersøkelse vil du åpne? 
 Spørreskjemaer (3) 
 Svangerskapsuke 20 (SPM20u) 
 Svangerskapsuke 32 (SPM32u) 
 Svangerskapsuke 36 (SPM36u) 
 Kostholdsskjema (6) 
 Svangerskapsuke 16 (M16uSjo) 
 Svangerskapsuke 32 (M32uSjo) 
 Barn 6 uker gammel (M6uSjo) 
 Barn 6 måneder gammel (M6mSjo) 
 Barn 12 måneder gammel (M12mSjo) 
 Barn 18 måneder gammel (M18mSjo) 
 Temperamentsskjema (8) 
 Barn 6 måneder gammel (M6mTemp) 
 Barn 12 måneder gammel (M12mTemp) 
 Barnets kosthold (1) 
 Barn 6 uker gammel (B6uKost) 
 Barn 6 måneder gammel (B6mKost) 
 Barn 12 måneder gammel (B12mKost) 
 Barn 18 måneder gammel (B18mKost) 
start_M16uSjo - Velkommen til Liten i Norge studien 
 
 
Takk for at du deltar og bidrar med viktig kunnskap om hva som påvirker barns utvikling.  
 
Denne gangen spør vi hovedsakelig om hva du spiser. 
 
Innsendingen av skjemaet blir kryptert. Opplysningene kan ikke knyttes til deg under overføringen.  
 
Start spørreskjemaet ved å klikke på " >> "-knappen neders på siden.  
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iSjo_infot1 - Her vil vi gjerne få informasjon om sjømatinntaket ditt. 
 
Ha de 3 siste månedene i bakhodet når du fyller ut skjemaet.  
 
Med sjømat mener vi fisk, fiskeprodukter og andre sjømatprodukter som for eksempel skjell og skalldyr. Vi er 
klar over at kostholdet varierer fra dag til dag. Prøv likevel så godt du kan å gi et "gjennomsnitt" av ditt 
sjømatinntak spist til middag, som pålegg, i salat og eller spist som mellommåltid. 
 
SjoDatet1 -  
 
Dato for utfylling: 
Hvis skjemaet ble fylt ut på en annen dato, må feltet oppdaters til denne datoen (dd.mm.åååå) 
 
SjoT1_1 - Hvor ofte har du spist fisk, fiskeprodukter eller annen sjømat som middagsmat de siste 3 mnd? 
 Aldri (1) 
 Sjeldnere enn 1 gang/måned (2) 
 1-3 ganger/ måned (3) 
 1 gang/uke (4) 
 2-3 ganger/ uke (5) 
 4 ganger eller mer/uke (6) 
SjoT1_2 - Når du spiser fisk, fiskeprodukter eller annen sjømat til middag, hvor mye spiser du vanligvis? 
(1 porsjon = 150 gram, tilsvarer for eksempel 1 laksekotelett eller 3 fiskekaker eller 2 dl reker u/skall) 
 ½ porsjon eller mindre (1) 
 1 porsjon (2) 
 1 ½ porsjon (3) 
 2 porsjoner (4) 
 3 porsjoner (5) 
SjoT1_3 - Hvor ofte har du spist sjømat som pålegg, i salat, mellommåltid, snacks eller lignende de siste 3 mnd? 
 Aldri (1) 
 Sjelden (2) 
 1-3 ganger/ måned (3) 
 1-2 ganger / uke (4) 
 3-5 ganger / uke (5) 
 Mer enn 5 ganger / uke (6) 
 
SjoT1_5 - Hvor ofte har du spist følgende sjømat som middag  siste 3 mnd? 
  
Aldri 
(1) 
Sjeldnere enn 1 
gang/måned (2) 
1-3 ganger /måned 
(3) 
1-2 ganger/uke 
(4) 
3 ganger eller 
mer/uke (5) 
Laks, ørret (1)      
Makrell (2)      
Sild (3)      
Kveite (4)      
Uer (5)      
Steinbit (6)      
Flyndre, rødspette (7)      
Torsk (8)      
Sei (9)      
Hyse (10)      
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Aldri 
(1) 
Sjeldnere enn 1 
gang/måned (2) 
1-3 ganger /måned 
(3) 
1-2 ganger/uke 
(4) 
3 ganger eller 
mer/uke (5) 
Abbor, gjedde (ferskvann) 
(11) 
     
Røye, sik (ferskvann) (12)      
Reker (13)      
Krabbe (14)      
Hummer (15)      
Blåskjell (16)      
Kamskjell (17)      
Sushi (18)      
Fiskekaker (19)      
Fiskeboller (20)      
Fiskepudding (21)      
Fiskegrateng (22)      
Fiskepinner (23)      
Fiskesuppe (24)      
Klippfisk (25)      
 
SjoT1_6 - Hvor ofte har du spist følgende sjømat som pålegg siste 3 mnd? 
 
Aldri 
(1) 
Sjeldnere enn 1 
gang/måned (2) 
 
1-3 ganger 
/måned (3) 
 
1-2 ganger/uke 
(4) 
3 ganger eller 
mer/uke (5) 
Makrell på boks (1)      
Sardin på boks (2)      
Laks på boks (3)      
Brisling (4)      
Ansjos (5)      
Røkt laks, ørret (6)      
Gravet laks, ørret (7)      
Reker (8)      
Tunfisk på boks (9)      
Sild (sursild, rømmesild, kryddersild 
el.lign.) (10) 
     
Kaviar (11)      
Crabsticks (12)      
Svolværpostei (13)      
Lofotpostei (14)      
Annet sjømat (15)      
SjoT1_6a - Annen sjømat 
Vennligst spesifiser: 
 
SjoT1_7 - Spiser du fiskerogn eller fiskelever? 
 Ja (1) 
 Nei (0) 
SjoT1_7a - Hvor mange ganger per år spiser du fiskeinnmat? 
 Aldri (0) 1-3 ganger/år (1) 4-6 ganger/år (2) 7-9 ganger/år (3) 10 ganger eller mer/år (4) 
Fiskerogn (1)      
Fiskelever (2)      
SjoT1_8a - Andre generelle spørsmål om kostholdet ditt: 
Hvor ofte spiser du frukt og grønnsaker? 
 
Sjeldnere enn 1 
gang/uke (1) 
1-3 
ganger/uke (2) 
 
4-6 
ganger/uke (3) 
 
 
1 gang/dag 
(4) 
 
2-3 
ganger/dag (5) 
4 ganger eller 
mer/dag (6) 
Frukt (inkludert juice og 
smoothie) (1) 
      
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Sjeldnere enn 1 
gang/uke (1) 
1-3 
ganger/uke (2) 
 
4-6 
ganger/uke (3) 
 
 
1 gang/dag 
(4) 
 
2-3 
ganger/dag (5) 
4 ganger eller 
mer/dag (6) 
Grønnsaker (2)       
SjoT1_8b - Spiser du meieriprodukter (melk, yoghurt, ost) daglig? 
 Ja (1) 
 Nei (0) 
SjoT1_8b1 - Hvor mange ganger per dag spiser du meieriprodukter? 
En gang er for eksempel ett glass melk eller en yoghurt eller ost til en skive brød 
 1 gang/dag (1) 
 2-3 ganger/dag (2) 
 4-6 ganger/dag (3) 
 7-9 ganger/dag (4) 
 10 ganger eller mer/dag (5) 
SjoT1_8b2 - Når det finnes vitamin D berikete varianter av de ulike meieriproduktene (for eksempel melk, yoghurt, 
ost), hvor ofte velger du da disse? 
 Aldri (1) 
 Sjelden (2) 
 Noen ganger (3) 
 Som oftest (4) 
 Alltid (5) 
 Vet ikke (6) 
SjoT1_8c - Hvor mange egg spiser du per uke? (stekt, kokt, eggerøre, omlett)? 
 Mindre enn 1 egg/uke (1) 
 1 egg/uke (2) 
 2-3 egg/uke (3) 
 4-5 egg /uke (4) 
 6-7 egg/uke (5) 
 8 eller flere egg/uke (6) 
SjoT1_8d - Bruker du smør eller margarin på skiven/knekkebrødet? 
 Ja (1) 
 Nei (0) 
SjoT1_8d1 - Fyll inn til hvor mange brødskiver/knekkebrød/rundstykker du vanligvis bruker smør/margarin per 
uke 
Margarin (1) ______________________________ 
Lettmargarin (2) ______________________________ 
Smør (3) ______________________________ 
SjoT1_8d2 - Hvor mye smører du pr. brødskive/knekkebrød/rundstykke? 
En porsjonspakning på 10-12 gram rekker til antall skiver/knekkebrød/rundstykke: 
 1 brødskive/knekkebrød/rundstykke (1) 
 2 brødskiver/knekkebrød/rundstykker (2) 
 3 brødskiver/knekkebrød/rundstykker (3) 
 4 brødskiver/knekkebrød/rundstykker (4) 
 5 brødskiver/knekkebrød/rundstykker (5) 
SjoT1_8e - Angi hvilken type fett du vanligvis bruker til matlaging 
 Aldri (1) Sjelden (2) Månedlig (3) Ukentlig (4) Daglig (5) 
Margarin (1)      
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 Aldri (1) Sjelden (2) Månedlig (3) Ukentlig (4) Daglig (5) 
Lettmargarin (2)      
Smør (3)      
Olivenolje (4)      
Soyaolje (5)      
Rapsolje (6)      
Solsikkeolje (7)      
Maisolje (8)      
Annen olje (9)      
SjoT1_8e1 - Vennligst spesifiser Annen olje 
 
SjoT1_8f - Når det finnes vitamin D berikete varianter av oljer, hvor ofte velger du da disse 
 Aldri (1) 
 Sjelden (2) 
 Noen ganger (3) 
 Som oftest (4) 
 Alltid (5) 
 Vet ikke (6) 
SjoT1_9a - Kosttilskudd: 
Har du tatt tran, fiskeolje- eller omega-3 tilskudd (flytende eller som kapsler) de siste 3 mnd? 
 Ja (1) Nei (0) 
Flytende (1)   
Kapsler (2)   
SjoT1_9b - Hvor mye flytende tran, fiskeolje eller omega-3 tar du per gang? 
 1 teskje (1) 
 1 barneskje (2) 
 1 spiseskje (3) 
SjoT1_9c - Hvor mange tran-, fiskeolje- eller omega-3 kapsler tar du per gang? 
 1-2 kapsler (1) 
 3-4 kapsler (2) 
 5 eller flere kapsler (3) 
SjoT1_9d - Hvilken type tran- eller fiskeolje/omega-3 tilskudd pleier du å bruke? 
 Bruker ikke 
(1) 
1-3 ganger/måned 
(2) 
1-3 ganger/uke 
(3) 
4-6 ganger/uke 
(4) 
Daglig 
(5) 
Møllers tran (1)      
Møllers dobbel (2)      
Krillolje (3)      
Selolje (4)      
Complete folat og omega-3 (5)      
Møllers omega-3 + folat (6)      
Gevita omega-3 med kalsium, vitamin D og 
K (7) 
     
Trippel Omega-3 (8)      
Lifeline gravid (9)      
Lifeline ammende (10)      
Nycomed gravid (11)      
Nycopluss omega-3 (12)      
Mulit-tabs GraviOmega (13)      
Annen (14)      
SjoT1_9d1 - Vennligst spesifiser hvilken annen type tran- eller fiskeolje/omega-3 tilskudd du bruker: 
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SjoT1_9e - Bruker du annet kosttilskudd (vitaminer og mineraler)? 
 Ja (1) 
 Nei (0) 
SjoT1_9e1 - Hvilke type kosttilskudd bruker du og hvor ofte 
 SjoT1_9e2 -  SjoT1_9e3 - Vennligst spesifiser 
hvilke(t) merke på kosttilskudd og  
hvor mye du tar hver gang 
 
Bruker 
ikke (0) 
1-3 ganger/ 
mnd (1) 
1-3 ganger/ 
uke (2) 
4-6 ganger/ 
uke (3) 
 
Daglig 
(4) 
Multivitaminer og 
mineral (1) 
     ______ 
Jern (2)      ______ 
B-vitaminer (inkl 
folsyre) (3) 
     ______ 
Kalsium og vitamin D 
(4) 
     ______ 
Annet (5)      ______ 
 
SjoT1_10 - Kryss av for feltene under som ev. gjelder for deg: 
 Er vegetarianer (1) 
 Har diabetes (sukkersyke) (2) 
 Er gravid/ammer (3) 
 Har matvareallergi/intoleranse (4) 
 Spiser ikke melprodukter (5) 
 Spiser ikke melkeprodukter (6) 
 Spiser ikke kjøttprodukter (7) 
 Spiser ikke grønnsaker (8) 
SjoT1_11a - Svangerskapskvalme 
Har du vært plaget med svangerskapskvalme? 
 Nei (0) 
 Ja, men bare deler av svangerskapet (1) 
 Ja, hele tiden (2) 
SjoT1_11b - Hvilken svangerskapsuke opphørte svangerskapsrelatert kvalme? 
 
SjoT1_11c - Har du kastet opp? 
 Nei (0) 
 Ja, men bare deler av svangerskapet (1) 
 Ja, hele tiden (2) 
SjoT1_11d - Hvilken svangerskapsuke opphørte svangerskapsrelatert oppkast? 
 
SjoT1_11e - Er det matvarer (mat, drikke, annet) du har spist/drukket spesielt mye av i svangerskapet (”cravings”)? 
 Nei (0) 
 Ja, men bare deler av svangerskapet (1) 
 Ja, hele tiden (2) 
SjoT1_11f - Spesifiser: 
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SjoT1_11g - Er det matvarer du har unngått å spise i svangerskapet på grunn av aversjon? 
 Nei (0) 
 Ja, men bare deler av svangerskapet (1) 
 Ja, hele tiden (2) 
SjoT1_11h - Spesifiser: 
 
SjoT1_11i - Er det matvarer du har unngått å spise av frykt for å skade barnet? 
 Nei (0) 
 Ja (1) 
SjoT1_11j - Spesifiser: 
 
SjoT1_11k - Er det matvarer du har begynt å spise fordi det kan være gunstig for barnet? 
 Nei (0) 
 Ja (1) 
SjoT1_11l - Spesifiser: 
 
SjoT1_12a - Solvaner 
Hvor ofte de siste 3 månedene har du brukt solarium? 
 Aldri (1) 
 Sjeldnere enn 1gang/måned (2) 
 1 gang/måned (3) 
 2-3 ganger/måned (4) 
 1-2 ganger/uke (5) 
SjoT1_12b - Hvor mange uker de siste tre månedene har du vært på badeferie (Norge eller Syden)? 
 Har ikke vært på badeferie (1) 
 1 uke (2) 
 2-3 uker (3) 
 4-6 uker (4) 
 7 uker eller mer (5) 
SjoT1_12c - Hvor mange dager/uker de siste tre månedene har du vært på fjellet i snø? 
 Har ikke vært på fjellet i snø (1) 
 1-6 dager (2) 
 7-13 dager (3) 
 2-3 uker (4) 
 4 uker eller mer (5) 
SjoT1_12d - Hvor mye utendørsaktivitet har du om sommeren (turer, hagearbeid, jobb)? 
 Lite (1) 
 Middels (2) 
 Ganske mye (3) 
 Ute nesten hele tiden (4) 
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SjoT1_13a - Andre spørsmål 
Alder, år (1) ______________________________ 
Høyde, cm (2) ______________________________ 
Vekt nå, kg (3) ______________________________ 
SjoT1_13b1 - Hvor mye veide du før du ble gravid (dette svangerskapet)? 
 
SjoT1_13c - Hvor ofte har du mosjonert sammenhengende i minst 30 minutter den siste måneden? 
 Aldri 
(1) 
Sjeldnere enn 1 gang/uke 
(2) 
1 gang/uke 
(3) 
2-3 ganger/uke 
(4) 
4-6 ganger /uke 
(5) 
Hver dag 
(6) 
Går (1)       
Jogger (2)       
Sykler (3)       
Svømmer (4)       
Sal (aerobic eller lingende) 
(5) 
      
Styrketrening (6)       
Annet (7)       
SjoT1_13c1 - Vennligst spesifiser hvilken annen form for mosjon 
 
SjoT1_13d - Hvor stor vekt legger du på å ha et sunt kosthold? 
 Svært liten (1) 
 Liten (2) 
 Middels (3) 
 Stor (4) 
 Svært stor (5) 
SjoT1_13f - Spiser du vanligvis ett eller flere måltider om dagen sammen med resten av familien? 
 Ja (1) 
 Nei (0) 
 Ikke relevant (2) 
SjoT1_kommentar - Eventuelle kommentarer til undersøkelsen: 
 
 
